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Abstract 
Inhibitory control refers to the ability to selectively attend to stimuli over a period of time and to 
inhibit unwanted responses. This ability is rarely compromised in patients with multiple sclerosis 
(MS), despite frequent impairment in other executive functions, even at early stages of the 
disease. The role of functional reorganization in the preservation of cognitive abilities has been 
documented in adults with MS, but has received little attention in children and adolescents who 
have MS. The current study examined: (1) inhibitory control using a Go/No-go task (GNG) in 
patients and age-matched controls; (2) the relationship between GNG performance and measures 
of cerebral tissue damage and age at disease onset; and (3) patterns of neural activation 
associated with inhibitory control on the GNG task.  Twenty pediatric-onset relapse remitting 
MS patients (13 females; age 19.36 ± 2.99) and 17 age-and sex-matched healthy controls (14 
females; age = 19.26 ± 2.63) performed a simple GNG task while in a 3T MRI scanner.  
Participants pushed a response button when they viewed a green spaceship (Go stimulus), but not 
when they viewed a red spaceship (No-go stimulus). Go versus No-Go stimuli were presented at 
a ratio of 5:1 over 2 blocks.  A brief neurocognitive screening assessment and questionnaires 
were also completed following the GNG task. Patients and controls did not differ with respect to 
IQ (p = 0.77), neuropsychological functioning on a battery of tests, nor on reaction time (p = 
0.13) and accuracy (p = 0.87) on the GNG task. Age at evaluation, fatigue, depression 
symptoms, and fine motor dexterity on the 9 Hole Peg Test did not correlate with GNG 
performance parameters. Younger age at disease onset (controlling for disease duration) was 
marginally associated with lower accuracy on the GNG task (r = 0.38, p = 0.054), suggesting that 
a less mature brain may be less capable of using functional reorganization as an adaptive 
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mechanism to preserve inhibitory control. Regarding structural MRI correlates of GNG 
performance, T1-weighted lesion volume trended with lower accuracy on the GNG task (r = -
0.32, p < 0.10).  Using a whole brain approach, the control group demonstrated greater functional 
activation than patients when inhibiting a response in the following eight brain regions: 
cerebellum, brainstem, lateral occipital cortex, parahippocampal gyrus, precuneus, superior 
parietal lobe, precentral gyrus and superior frontal gyrus. These findings demonstrate that 
cognitively intact pediatric-onset MS patients recruit fewer brain regions than controls on a 
simple inhibitory control task.  In particular, functional abnormalities of the posterior and 
anterior regions of the response inhibition network in the MS group were identified.  Overall, 
findings contribute to our understanding of brain network disruption in cognitively intact 
pediatric-onset MS patients. 
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Introduction 
 To date, research has focused on the identification and characterization of cognitive 
impairment in pediatric-onset multiple sclerosis (MS). Studies have focused on understanding 
clinical and neural correlates of cognitive dysfunction in this population in order to better predict 
who is at risk of cognitive impairment. Less is known about how the developing brain may adapt 
to the disease processes that characterize MS. Given that MS is a dynamic disease that involves 
ongoing demyelination, remyelination, axonal loss, and cell death, a weak to moderate 
relationship exists between neuropsychological measures and structural magnetic resonance 
imaging (MRI) indices. Fluctuations in the appearance of lesions and changes in brain volume 
metrics associated with disease pathology likely contribute to these relatively weak relationships.  
Moreover, structural imaging does not provide information regarding functional brain changes 
that may occur during the course of disease.  
The brain’s potential to reorganize can be investigated using functional neuroimaging 
techniques.  Indeed, the role of functional reorganization in the preservation of cognitive abilities 
has been documented in adults with MS, but has received little attention in children and 
adolescents who have MS. Thus, the goal of the current study is to use functional MRI 
techniques to explore whether neuroplasticity is observed on a simple inhibitory control task 
(Go/No-go task) for which we expect pediatric MS patients to perform at a behavioral level 
similar to healthy controls. We will test the hypothesis that patients with MS will show greater 
recruitment of frontal brain regions when performing this low cognitive load attention task 
relative to controls.  This increased cortical recruitment is believed to represent compensatory 
mechanisms in the patient population. 
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Overview of Multiple sclerosis   
 Multiple sclerosis (MS) is a life-long inflammatory, demyelinating and 
neurodegenerative disease that can occur in childhood.  The worldwide prevalence of MS is 
estimated at 50:100,000, with 2.7-5% (1.35-2.5:100,000) of these cases occurring before the age 
of 18 years, and about 0.2-0.7% (0.4-1.4:100,000) occurring during infancy and early childhood 
(Duquette et al. 1987; Ruggierir, Polizzi, Pavone, & Grimaldi, 1999; Yeh et al., 2009). In 
Canada, an incidence of pediatric-onset MS is found in 0.9 per 100,000 Canadians (Banwell, 
Ghezzi, Bar-Or, Mikaeloff, & Tardieu, 2007). 
  The disease process is characterized by inflammation and demyelination of the brain and 
spinal cord that lead to scarring known as “sclerosis”. This damage may lead to lesions 
preventing the transmission of nerve signals. Depending on the location and extent of these 
lesions, physical or cognitive deficits of varying severity may occur (Ghezzi et al., 2002). While 
demyelination is the most characteristic feature of MS, recent studies (Mesaros et al., 2008) 
show that neurodegenerative processes are also involved. Thus, damage extends beyond myelin 
and oligodendroglial cells and involves grey matter as well. Recent work in pediatric MS has 
shown substantial loss of both grey matter and white matter volume (Mesaros et al., 2008). 
Volume loss in the thalamus is particularly notable and can occur prior to observable volume 
loss in the whole brain (Kerbrat et al., 2012; Mesaros et al., 2008).   
Some notable differences exist in terms of disease burden and MRI activity in pediatric 
patients as compared with and adult patients with MS.  A study of 41 pediatric and 35 adult-
onset MS patients examined MRI characteristics at time of first MS symptoms and at follow-up 
(Waubant et al., 2009).  Results found that pediatric-onset MS patients had (1) a higher number 
of total T2 and larger T2-bright areas than adult-onset MS patients at initial scanning and(2) 
more T2-bright foci in the posterior fossa.  Follow-up scans found that pediatric-onset MS 
3 
 
patients had more new T2-bright and gadolinium enhancing foci than adult onset. Thus, 
pediatric-onset MS patients not only had a higher disease burden but also had greater posterior 
fossa involvement and a higher rater of new lesions compared to adult-onset MS patients, 
controlling for disease duration. These differences in lesion location and activity may indicate 
differences in disease burden and clinical outcome in the two groups.  
A relapsing-remitting course of disease is present in over 95% of children (Banwell et al., 
2007). In relapsing-remitting MS (RRMS), patients experience acute and worsening attacks 
followed by subsequent periods of remission with either partial or complete recovery to pre-
attack function. The time between attacks can range from months to years (Banwell et al., 2007). 
Cognitive Impairment in Pediatric-Onset Multiple Sclerosis  
Cognitive impairment occurs in 30-50% of children and adolescents with MS and may be 
severe enough to compromise intellectual functioning, academic performance, and daily life 
function (Amato et al., 2008; Banwell & Anderson, 2005; MacAllister et al., 2005; Till et al., 
2011). Most studies report that cognitive deficits can be detected across multiple domains, 
including information processing speed, attention, episodic memory, language (receptive, verbal 
fluency, naming), as well as some aspects of visual-spatial and visual-motor function (Ghezzi, 
Goretti, Portaccio, Roscio, & Amato, 2010). Executive dysfunction is also demonstrated, 
particularly with regard to working memory and cognitive flexibility, whereas inhibitory control, 
as assessed on continuous performance tests, in general, is less compromised (Till et al., 2012). 
Children and adolescents with MS may also experience difficulty with functioning in a regular 
classroom, reduced participation in hobbies and sports, and may experience fatigue and affective 
disorders. All of these difficulties may contribute to social difficulties (Ghezzi et al., 2010).  
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Clinical correlates of cognitive impairment. Cognitive impairment in pediatric-onset 
MS patients has been associated with increased physical disability as assessed using the 
Expanded Disability Status Scale (EDSS) (Kurtzke, 1983), a higher number of relapses, younger 
age at onset, and longer disease length (Banwell et al., 2007). Studies have shown that children 
with a younger age of disease onset, as opposed to a later age of disease onset, are more likely to 
experience cognitive dysfunction, particularly on tasks that require self-generated organizational 
strategies, efficient processing speed or working memory (Banwell & Anderson, 2005; 
MacAllister et al., 2005). Several hypotheses have been put forth to help explain the increased 
vulnerability of the developing brain. First, the combination of incomplete myelinogenesis and 
demyelination of the immature central nervous system may impair neuronal network formation, 
thereby increasing the risk of the cognitive impairment in patients with a young disease onset. 
Second, pediatric patients have less established skills at time of disease onset and developing 
skills may be more susceptible to disruption than established ones. Third, functional recovery or 
use of compensatory strategies may be restricted by the young child’s limited repertoire of 
existing skills.  
Younger age at onset is analogous to an adult patient with a low cognitive reserve. 
Cognitive reserve theory (Stern, 2002) states that individuals differ in their cognitive efficiency 
used to process information.  An individual’s cognitive reserve can be estimated by premorbid 
intelligence (often estimated by vocabulary knowledge) or by educational attainment. In MS, 
higher cognitive reserve serves to: (1) protect individuals from cognitive impairment that can 
result as a function of diffuse brain pathology; and (2) allow patients to perform on information 
processing tasks similarly to healthy controls (Sumowski, Chiaravalloti, Wylie, & DeLuca, 2009; 
Arnett, 2010; Benedict, Morrow, Guttman, Cookfair, & Schretlen, 2010). Adults with MS who 
have a higher education are more likely to display cognitive compensatory mechanisms (Bonnet, 
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Deloire, Salort, Dousset, Petry, & Brochet, 2006) and are better able to withstand acquired 
neuropathological changes than adult MS patients who have a lower level of education. Thus, an 
individual’s level of cognitive reserve may serve to protect against neurocognitive decline 
secondary to the disease.  
Children with MS -- as a result of their young age -- have less developed networks, which 
is analogous to having a low cognitive reserve in adulthood. Because the disease impacts 
children and adolescents during critical periods of brain development when knowledge and skills 
are being rapidly acquired, young onset of the disease may increase risk of cognitive impairment 
relative to an older onset of disease.  
MRI correlates of cognitive impairment. MRI techniques have shown that reduced 
volume in the thalamus and in the entire brain is moderately associated with lower cognitive 
performance in pediatric-onset MS patients (Till et al., 2011). These findings suggest that 
pediatric-onset MS patients do not exhibit protective factors against the influence of MS on brain 
integrity. Moreover, the relationship between thalamic volume loss and reductions in global 
cognitive functioning, mental processing speed, visuomotor integration and expressive 
vocabulary suggests that the thalamus plays an important role in cognitive processes that require 
the integration of many brain regions. Similar associations between reduced thalamic size and 
global cognitive dysfunction have been reported in adults with MS (Riccitelli, Rocca, Pagani, 
Rodegher, Rossi, Falini, et al., 2011).   
Normalized brain volume (i.e. corrected for head size) is considered to be a measure of 
overall brain health. In pediatric onset MS, a reduction in normalized brain volume has been 
documented (Kerbrat et al., 2012; Till et al., 2011), and this may reflect an overall failure of the 
brain to develop at an age appropriate rate. Reduction in cerebral volume has been associated 
with poorer performance on a measure of verbal learning and memory to the same extent as a 
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reduction in hippocampal volume (Fuentes et al., 2012). These findings suggest that both diffuse 
and focal pathology can contribute to learning and memory performance – consistent with the 
idea that learning and memory involve both cortical and subcortical brain regions.   
Lesion volume is typically less strongly correlated with measures of cognition and 
physical disability, perhaps reflecting the poor anatomical specificity of this index of 
pathological damage (Rovaris et al., 1998). In other words, high lesion volume may not associate 
strongly with a clinical outcome if the brain regions affected are not related to the specific 
clinical outcome (i.e. a large lesion in the brainstem versus the frontal lobes will have different 
clinical outcomes), or it may be the result of many diffuse small lesions throughout the brain. A 
second reason why lesion volume may not be a robust correlate of cognition is because cognitive 
impairment can be found in the absence of lesioned tissue and instead reflect neurodegenerative 
processes that can also impact cognition (Rovaris, Comi, & Filippi, 2006). Thirdly, lesion 
volume may not strongly correlate with cognition since the neurons may merely be inflamed (as 
detected by T2-weighted imaging) rather than permanently damaged; thus, when the 
inflammation remits, the neurons may return to normal function (Miller, Grossman, Reingold, & 
McFarland, 1998).  
Diffusion tensor imaging (DTI) is another type of quantitative neuroimaging method that 
is sensitive to detecting disruption to white matter microstructure in MS. This technique can be 
used to identify pathological changes in white matter before lesions or atrophy becomes visible 
(Rovaris et al., 2006). Studies have shown that reduced fractional anisotropy (a measure of white 
matter integrity) in the corpus callosum is associated with slower processing speed in adults with 
MS (Roosendaal et al., 2009) as well as children with MS (Bethune et al., 2011; Till et al., 2011).   
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Summary 
  Cognitive impairment is an important sequela of pediatric-onset MS. The extent of 
cognitive impairment appears to be moderately correlated with global and regional brain volume 
loss. Further work is required to understand other possible factors that may play a role in limiting 
the clinical expression of damage associated with the disease. Using functional MRI (fMRI) 
techniques, we may be able to uncover other factors that help to explain why some children are 
spared cognitive impairment despite the accrual of multiple lesions and loss of brain volume 
during the course of the disease. One possibility is that youth with MS rely upon functional 
reorganization of non-injured tissue to assume functions of damaged tissue. The capacity for 
compensatory strategies may explain why some developing executive functions, such as 
inhibitory control, do not show impairment in young individuals with MS. The next section will 
examine the functional neuroimaging literature conducted in patients with MS with a focus on 
brain activation patterns that are associated with “normal” behavioural outcomes in this 
population. 
Relating brain damage to adaptive functional reorganization in patients with MS 
 Adaptive functional reorganization in patients with MS is defined as changes in brain 
neural pathways that permit the individual to perform similarly to pre-insult level. Studies have 
shown that cognitively preserved adult patients with MS recruit additional brain areas to perform 
tasks of memory and attention at the same level as healthy controls (Audoin, Van Au et al., 2005; 
Chiaravalloti et al., 2005; Bonnet, et al., 2010). The observed increase in brain activation is 
interpreted as a functional or neural compensatory mechanism since the brain must work harder 
(i.e. require more blood flow to new brain regions) to achieve the same level of behaviour. Of 
note, while overall behavioural performance in the patients does not significantly differ from 
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controls on these tasks, reaction time tends to be slightly slower (Audoin, Van Au, Ranjeva, 
Ibarrola, Malikova et al., 2005; Chiaravalloti et al., 2005; Bonnet et al., 2010). 
The potential for functional reorganization appears to be limited by the brain’s ability to 
recruit more brain regions (Schoonheim, Geurts, & Barkhof, 2010). As shown in Figure 1, the 
initial structural damage occurring early in the disease (i.e. Phase 1) is associated with a steep 
increase in the extent of hyperactivation in the brain. This increase represents a functional 
reorganization response to the structural damage and allows for preservation of cognitive 
functioning to occur. Evidence in support of functional reorganization in adults with MS is 
demonstrated by greater activation of brain areas (i.e. quantitative differences), as well as the 
recruitment of additional brain areas (i.e. topographic differences).  These differences are 
described in detail in the next section.  
Phase 2, as shown in Figure 1, refers to the extent of increased structural damage, which 
in turn, is associated with a stronger response in functional reorganization. Importantly, there is a 
finite capacity for the system’s ability to demonstrate functional reorganization; in other words, 
the brain’s ability to recruit additional regions reaches its peak once the extent of structural 
damage in the brain reaches a maximal threshold for functional reorganization. Because the 
capacity for functional reorganization is now limited, this is the point at which clinical disability 
becomes more pronounced.   
In Phase 3, clinical disability becomes progressive with increasing structural damage and 
a decreasing capacity of the brain for functional reorganization. The inverse relationship between 
the severity of clinical disability and the degree of functional reorganization that is possible is 
referred to as the “disease progression hypothesis” (Schoonheim et al., 2010). According to this 
hypothesis, it is suggested that patients with MS who have mild cognitive impairment may be 
recruiting more brain regions to compensate; In contrast, those with severe cognitive impairment 
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are more likely to have increased structural damage in the brain, which in turn, results in a 
limited capacity of the brain to recruit additional ‘healthy’ areas for functional reorganization to 
occur (Schoonheim et. al., 2010).  
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Figure 1. Multiple Sclerosis disease progression hypothesis (Schoonheim et al., 2010). 
 Initially, very little structural damage causes a strong response in functional reorganization and 
hyperactivation in the brain, resulting in low disability and cognitive preservation in phase 1. 
After functional reorganization reaches its peak in phase 2 and decreases thereafter, cognitive 
impairment and disability progressively develop throughout phase 3.  
 
 
 
 
 
 
 
 
11 
 
 Evidence for the disease progression hypothesis in MS (Schoonheim et al., 2010) comes 
from a functional MRI study conducted in sixteen patients who were in the early stages of MS 
and had varying degrees of cognitive impairment (Hawellek, Hipp, Lewis, Corbetta, & Engel, 
2011). The study examined how cognitive inefficiency (defined as a decrease in processing 
speed, executive functions and attentional control) is associated with MS-related changes in 
structural and functional connectivity in the default mode network (DMN), which is the network 
that is active during rest, and the control network, which refers to the network implicated in the 
deployment of attention and cognitive control (Hawellek et al., 2011). Functional connectivity 
provides information about how the brain is networked and what networks are activated when 
completing a given task. Thus, functional connectivity can be used to identify distinct functional 
networks that may be disrupted by diffuse pathology. Relative to healthy controls and to less 
cognitively impaired MS patients, the patients with low cognitive efficiency scores exhibited 
increased functional connectivity in the DMN and the control network. Consistent with the 
disease progression hypothesis, reduction in white matter volume (a marker of atrophy in the 
brain) was associated with a loss in cognitive efficiency and greater functional connectivity. Put 
another way, patients with cognitive impairment when compared to controls showed greater 
activation in both the default mode and cognitive control networks in the face of having greater 
structural damage (i.e. reduction in anatomical connectivity). This result is counterintuitive to the 
prominent view that a pathological loss in function is reflected through a loss of fluctuations in 
dedicated brain systems as seen in other neurological populations such as stroke (Carter et al., 
2010). MS may differ from these other pathologies as a result of the diffuse impact it has on the 
white matter integrity and the CNS networks, which in turn may account for the counterintuitive 
results showing greater functional connectivity in the face of structural brain damage (Hawellek 
et al., 2011).  
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There is only one study to date that has examined the idea of compensatory cerebral 
recruitment in pedsMS (Rocca, Absinta, Ghezzi, Moiola, Comi, & Filippi, 2009).  This study 
used a simple motor task involving repetitive flexion-extension of the last four digit fingers to 
examine the pattern of cortical activation associated with simple movement. Relative to age-
matched controls, pediatric MS patients (all right-handed) showed increased activation of the left 
primary sensorimotor cortex during the performance of this simple motor task, indicating that 
patients have a greater need to recruit more areas in order to perform the same task as age-
matched controls. A secondary objective of this study was to examine the relationship between 
the extent of T2-weighted lesion volume and the degree of movement-associated brain 
activation. Results showed that the increased activation of the primary sensorimotor cortex was 
moderately correlated with the extent of T2 lesion volume. These findings are consistent with the 
idea that greater cerebral pathology is associated with a greater need to recruit additional brain 
regions as a compensatory mechanism.  
Summary   
The relationship between severity of disease and the brain’s potential to reorganize has 
been documented using functional neuroimaging techniques in both adult- and pediatric-onset 
MS. Consistent across the functional neuroimaging studies is a lack of between-group difference 
on the task that is being performed. It is important to compare groups on tasks for which the 
behavior is similar across groups, as differences between groups would make interpretation of 
functional brain data difficult, if not impossible. While functional neuroimaging has been used to 
assess the role of functional reorganization in the preservation of cognitive abilities in adults with 
MS, little work has been done in this area with children and adolescents who have MS. The next 
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section will focus on brain activation patterns that are associated with attentional control and 
response inhibition, a behaviour that is typically preserved in pediatric-onset patients with MS.  
Attentional control and Response Inhibition  
 Attentional control involves the ability to selectively attend to stimuli over a period of 
time and response inhibition refers to the ability to inhibit unwanted responses. The ability to 
inhibit an unwanted response involves regulation and monitoring of one’s actions so that goals 
are met. Attentional control also relies on working memory, especially in cases where the 
environment is rich with distracters and the individual is required to keep information in mind in 
order to be able to select, update, maintain and retrieve this information when needed (Redick, 
Calvo, Gay, & Engle, 2011). Difficulties with attentional control and response inhibition may be 
associated with impulsivity, lack of self-control, inability to finish tasks, and careless mistakes.    
The developmental course of response inhibition begins as early as 12 months when the 
ability to inhibit certain behaviours and learn new responses is demonstrated. Around age 3, 
children are capable of inhibiting behaviours, but still make perseverative errors occasionally. 
Around age 6, children’s speed and accuracy of impulse control improves, and by age 9, they are 
able to monitor and regulate their actions more effectively (Anderson, Jacobs, & Harvey, 2008). 
Along a similar time frame with response inhibition, working memory begins to emerge in 
infancy and consolidate in middle to late childhood. These maturational changes coincide with 
brain development – in particular the growth of the frontal lobes, which are necessary for both 
attentional control and response inhibition (Anderson et al., 2008; Davidson, Amso, Anderson, & 
Diamond, 2006).   
Measurement of Attentional Control and Response Inhibition.  Attentional control 
and response inhibition can be assessed using a variety of methods, including the Flanker task 
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(Gómez-Guerrero et al., 2011), Stroop task (Ikeda, Okuzumi, Kokubun, & Haishi, 2011), and the 
Go/No-go task.  In the Go/No-go task, which is used in the current study, participants must 
respond as quickly as possible to the Go stimulus, but inhibit responding to a No-go stimulus. 
There are many different versions of the Go/No-go task, but the paradigm developed by 
Mostofsky et al. (2003) will be reviewed here because it relates to the methods used in the 
current study. This task has been used with children in the MR scanner and is considered a 
simple Go/No-go task because it only has two stimuli that require attention. Basically, the 
Go/No-go task requires the participant to discriminate between two stimuli. The “go stimulus” – 
a green spaceship - requires the participant to respond by pushing a button whereas the “no-go 
stimulus” – a red spaceship - requires the participant to withhold a button press. The 
discrimination of these simple stimuli (i.e. green vs. red spaceships) minimizes the influence of 
cognitive demands, such as working memory, thereby making it possible to study the systems 
involved in inhibition of a simple motor response (i.e. finger press) (Mostofsky et al., 2003). 
Task stimuli also have a familiar colour cue-response association (green for Go; red for No-go) 
thereby minimizing the influence of cognitive demands (Mostofsky et al., 2003). The task is 
weighted toward Go stimuli (using a 5:1 ratio) in order to build up a tendency to respond with a 
button press and to increase the effort required in inhibiting a response when a No-go stimulus is 
presented. Moreover, both types of cues (i.e. Go and No-go) are presented at a rapid rate, which 
serves to increase the demand on the system involved in attentional control.   
A Go/No-go task is optimally presented as an event-related design in the scanner. In this 
type of design, the brain activation areas associated with a No-go stimulus response can be 
contrasted with baseline or Go stimulus trials. However, comparing the No-go stimulus response 
to the Go stimulus response is problematic since the two events (to respond or withhold a 
response) are not independent, and there may be overlapping activation patterns in making a 
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decision in both types of responses (Simmonds, Pekar, & Mostofsky, 2008). Another problem 
with comparing a Go versus No-go response is that one condition involves a motor response and 
the other does not. A better solution to understanding brain region activations specific to 
attentional control would be to compare a Go response (in a typical Go/No-go paradigm) against 
a simple button press to a paradigm that does not require visual discrimination and decision 
making.     
A block design is a less optimal design because it is difficult to determine if the activation 
patterns reported are truly a result of attentional control (Mostofsky et al., 2003). The block 
design approach examines attentional control by contrasting a block with both Go and No-go 
stimuli to a block with only Go stimuli. This approach is based on the idea that by contrasting the 
mixed block with the Go stimulus block, it is possible to isolate activation areas specific for 
attentional control. However, a problem with this approach is that the two blocks may differ 
simply because the mixed block requires the participant to have a higher level of vigilance than 
the Go-stimulus block. The mixed block requires activation of multiple systems involved in the 
recognition of different cues and in making decisions about the appropriate response (Mostofsky 
et al., 2003), rendering the block design as a non-ideal method for assessing attentional control. 
A more optimal approach is to use an event-related design which characterizes the stimulus, 
delay period and response time as separate events. This approach, when timed appropriately with 
scanning time, provides the opportunity to observe neural activity based on a BOLD signal 
associated with the part of the event one is interested in (in the present study it involves 
withholding the response). By comparing No-go to baseline, one is examining the regions 
commonly associated with response inhibition. Comparing Go versus No-go to examine 
response inhibition may remove regions that serve an important role in response inhibition 
because they are also involved in response selection (Mostofsky et al., 2003). 
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 Functional brain activation related to attentional control and response inhibition in 
healthy controls.  Functional MRI studies using the Go/No-go task in healthy adult controls 
have furthered our understanding of the neural activity associated with attentional control and 
response inhibition. Importantly, the regions of activation in the brain differ depending on the 
phase of the task, type of response (i.e. “go” versus “no go”), as well as the type of task that is 
being used (i.e. simple versus complex Go/No-go task). For the purpose of the current review, 
activation related to simple Go/No-go tasks with right-handed responses will only be discussed. 
During the preparation phase, significant brain activation is observed in bilateral, diffuse regions 
including the left dorsal premotor, left lateral occipital, right ventral premotor, right fusiform 
gyrus, and the right anterior cingulate-sensorimotor cortex (Watanabe et al., 2002). Activation in 
these brain regions is related to the preparation for motor execution and increased attention 
required for visual discrimination. Specifically, the supplementary motor area (SMA) and 
premotor cortex play an important role in preparatory process of motion whereas the left 
occipital area and right fusiform gyrus play a role in colour and target discrimination. With 
regard to “no go” versus “go” responses, a right-lateralized network has been associated with 
response inhibition (i.e. to orient and prepare for the No-go response) whereas efficiency of 
responding to the “go” stimulus (indicated by shorter reaction time on go trials and a higher 
percentage of correct no-go trials) appears to involve a more left lateralized network (Hirose, 
Chikazoe, Watanabe, Jimura, Kunimatsu, Abe et al., 2012)  
Recently, Simmonds et al. (2008) performed an activation likelihood estimate (ALE) 
meta-analysis of five studies examining the pattern of neural activation in healthy adults 
performing simple Go/No-go tasks (i.e. in which stimulus-response associations remained 
constant) and another five studies conducted using complex Go/No-go tasks (i.e. in which 
stimulus-response associations had to be manipulated based on information in working memory). 
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Using an event-related contrast of “No-go versus baseline”, regions that were common to 
successfully inhibited No-go stimuli across the five studies that used the simple Go/No-go tasks 
were then characterized. Result from this analysis associated successfully inhibited responses 
(not responding to the “no-go” stimulus) with a primarily right-lateralized network. The specific 
brain regions involved the right pre-SMA [Brodmann Area (BA) 6], right precuneus (BA 7), 
right inferior occipital gyrus (BA 19), and the left fusiform gyrus/posterior cerebellum (BA 
19/37).  
Previous human lesion studies and imaging studies lend support to the importance of the 
pre-SMA (also known as the superior medial wall) not only in motor preparation (responding to 
a Go stimulus) but also in response inhibition (withholding a response to a No-go stimulus). Poor 
inhibitory response is associated with lesions in the superior medial frontal lobe (Floden & Stuss, 
2006; Picton et al., 2006). The pre-SMA is activated during response inhibition tasks (Bellgrove, 
Hester, & Garavan, 2004; Mostofsky et al., 2003), and motor response preparation and selection 
(Barber & Carter, 2005), whereas the left fusiform gyrus is a visual association area that has 
connections to the posterior parietal and prefrontal areas (Pandya & Seltzer, 1982), which may 
be needed to correctly recognize the cue or provide feedback whether to inhibit the response 
(Simmonds et al., 2008).  
It should also be noted that activation differences are reported between correct and 
incorrect responses (errors of commission). Using a simple Go/No-go task whereby participants 
respond to a particular stimulus (“X”) and withhold responding to a different stimulus (“K”), 
Kiehl, Liddle, and Hopfinger (2000) report extensive activation in the rostral anterior cingulate 
cortex and left lateral frontal cortex when a commission error was made. These regions are 
implicated in error related processes and are thought to serve as the brain’s error monitoring 
system.  
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 Functional brain activation related to attentional control and response inhibition in 
patients with MS.  Several studies using the Go/No-go paradigm have reported differences in 
the regions and extent of activation demonstrated in patients with MS as compared with controls. 
In a sample of 15 patients with RRMS who were characterized by recent disease onset and 20 
controls, Bonnet et al. (2010) examined performance on the Go/No-go paradigm using 4 
conditions that increased in difficulty. The conditions included:  (1) a tonic alertness condition 
where participants had to press a button every time they saw a figure on the screen; (2) a simple 
Go/No-go condition where participants had to respond to the target and withhold responding to 
the distracter; (3) a reverse condition where the target and distracter were reversed; and (4) a 
complex Go/No-go condition where there were 2 targets and 5 distracters. Results showed that 
patients performed the tasks as well as controls with the exception of the complex task on which 
patients were slower. Neuroimaging results showed that relative to controls, patients with higher 
performance (as measured by faster reaction times) had greater activation in the medial frontal 
gyrus. In the simple and complex conditions, cerebral activation patterns were greater in patients 
than controls thus implicating the involvement of distributed neuronal networks as a functional 
compensatory mechanism. The specific brain areas activated on each condition in patients 
compared with healthy subjects included the (a) left SMA, left cingulate gyrus, right dorsolateral 
prefrontal cortex (DLPFC), left occipital and temporal gyrus, left parahippocampal gyrus, left 
precentral gyrus, right cerebellum for the tonic condition; (b) right cingulate gyrus, right 
cerebellum, right temporo-occipital for the simple Go/No-go condition; (c) right  DLPFC, left 
temporal lobule, bilateral superior parietal gyrus, and bilateral cerebellum for the reverse Go/No-
go condition; and the (d) left thalamus, left temporo-occipital, right cingulate gyrus, right 
temporo-parietal, right temporal gyrus and the right cerebellum for the complex Go/No-go 
condition. Consistent with Phase 3 of the disease progression hypothesis, Bonnet et al. (2010) 
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found that patients with MS were unable to complete the complex Go/No-go task similar to 
controls when the cognitive load was so great that the cerebral compensatory mechanisms had 
become saturated. On the complex condition, patients exhibited a collapse of supplementary 
cerebral recruitment (as shown on the simple Go/No-go condition) and significantly longer 
reaction times compared with controls. Another important finding was that patients recruited 
medial frontal regions that were not recruited by controls. A final result of this study was that a 
higher degree of tissue damage was significantly correlated with greater activation in frontal 
regions. The more diffuse the tissue abnormalities (as assessed using lesion load and 
magnetization transfer ratio metrics of normal appearing brain tissue), the greater the frontal 
activation. This tendency to recruit higher-level decision making areas, including the prefrontal 
regions, suggest changes in strategies to compensate by patients with MS who suffer from 
widespread pathology in the brain. 
In a recent study by Loitfelder et al. (2011), Go/No-go task performance was compared 
between healthy controls and three patient groups: those with clinically isolated syndrome (CIS), 
RRMS, and secondary progressive multiple sclerosis (SPMS). Patients with CIS are described as 
having a first neurological episode that results from inflammation/demyelination in the CNS and 
these individuals may or may not develop MS, whereas SPMS is one of the four recognized 
forms of MS and is characterized as a steady progression of neurological damage that may 
contain relapses with only minor remissions (Rog et al., 2010). Results showed varying 
activation levels depending on the severity of brain damage. More specifically, patients with CIS 
(who characteristically have the least amount of brain insult compared to the other clinical 
groups) demonstrated no difference in activation patterns when compared to controls. In contrast, 
patients with RRMS when compared to patients with CIS had a relative increase in activation 
patterns in the precuneus, both superior parietal lobes, and the right fusiform gyrus --despite 
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similar cognitive profiles. Taken together, these findings indicate compensatory strategies 
amongst the patients with more diffuse brain insult, but not amongst the CIS patients who are not 
characterized by diffuse brain insult. Patients with SPMS in comparison to patients with CIS had 
the worst neuropsychological performance and the most abnormal activation patterns as 
indicated by activation in diverse frontal and parietal regions. These findings lend further support 
to the idea that compensatory neuronal activation exists, but only to a certain point. Once the 
neuronal damage exceeds this threshold, an increase in neuronal recruitment pattern is no longer 
beneficial.   
In another study by Smith et al. (2009), ten cognitively impaired adult patients with MS 
and ten healthy controls performed a Go/No-go task while in the scanner. Results showed that 
the MS patients performed significantly worse than controls in the ability to inhibit responses as 
indicated by a higher number of commission errors. Correlational analysis indicated that those 
with slower reaction times also had a lower degree of cognitive flexibility as measured by the 
Wisconsin Card Sorting Task. Results showed that patients had more neuronal activity than 
controls in the fusiform gyrus, cingulate gyrus, anterior cingulate, insula, putamen and 
cerebellum, with less activity than controls in the left supramarginal gyrus. Despite over-
activation of several key brain regions, these patients were not able to achieve the same level of 
performance as controls. An explanation for why the over activation of brain regions was not 
associated with better performance in this study may be because these patients were more 
impaired cognitively relative to prior studies where the MS sample were either early in the 
disease process or were characterized as having minimal to no cognitive impairment. Another 
difference to explain why task performance of these patients was poor may relate to the finding 
showing reduced activation in the left supramarginal gyrus. This region is involved in sensory 
feedback during motor tasks and in awareness of errors (Hester, Foxe, Molholm, Shpaner, & 
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Garavan, 2005), suggesting that patients were not aware of their mistakes. Finally, it is possible 
that recruitment of more frontal brain regions, such as the dorsolateral prefrontal cortex 
(DLPFC), is needed for improving performance on the task.   
Studies examining response inhibition using Go/No-go offer mixed results in terms of 
task performance and degree of brain activation. Studies where there is little cognitive 
impairment found in patients compared to healthy controls report increased degree of activation 
as being beneficial to supporting similar task performance (Bonnet et al., 2010). Mixed results 
come from studies reporting diffuse damage, where some studies report increased brain 
activation patterns as being beneficial to task performance (Loitfelder et al., 2011) whereas 
others report an over-activation of brain regions as not benefiting task performance (Smith et al., 
2009). Although literature examining the idea of cerebral compensatory strategies in adult MS is 
growing, the relationship between increased brain activation and better task performance in 
patients with cognitive impairment remains unclear.  
Purpose 
 Studies have shown that response inhibition is rarely compromised in adult patients with 
MS (Bonnett et al., 2010) as well as children and adolescents with MS (Till et al., 2012). Using 
functional MRI techniques, we can better understand why this executive function remains 
relatively preserved in pediatric-onset MS patients, despite frequent impairment in other 
cognitive domains, such as processing speed and attention, at early stages of the disease (Till et 
al., 2012; Till et al., 2011).  If we identify differences in the activation patterns of patients 
compared with controls when performing a simple Go/No-go task that requires inhibitory 
control, we will improve our understanding of potential neuroplastic mechanisms that these 
young patients may use to maintain age-appropriate inhibitory control. These findings would 
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provide evidence suggesting that the developing brain is capable of using functional 
reorganization as an adaptive mechanism to offset impairment in this important executive 
function. The specific objectives and hypotheses of the proposed study are as follows: 
Objective 1.  To examine response inhibition in pediatric-onset MS patients and age-
matched controls using a simple Go/No-go task 
  Consistent with the neuropsychological literature in pediatric-onset MS (Till et al., 
2012), we do not expect cognitively intact pediatric-onset patients with MS to demonstrate 
deficits on the simple Go/No-go task with respect to accuracy and reaction time.  
Objective 2.  To evaluate the influence of age at disease onset and cerebral tissue damage 
on Go/No-go performance parameters  
  Given that attentional control and response inhibition networks continue to develop 
throughout childhood and into adolescence, it is hypothesized that younger age at disease will be 
associated with poorer performance on the Go/No-go task.  Moreover, MRI metrics of cerebral 
tissue damage, including lesion volume, brain volume and thalamic volume, are expected to be 
weak to moderate correlates of reaction time and accuracy on the Go/No-go task given prior 
literature examining the association between structural MRI metrics and measures of cognitive 
performance. 
Objective 3.  To examine whether cognitively intact childhood-onset MS patients produce a 
less efficient pattern of cerebral activation compared with age-matched healthy controls 
 Using a whole brain approach, we hypothesize that pediatric-onset MS patients will 
recruit supplementary cerebral areas in addition to greater activation in expected brain regions 
when performing a simple Go/No-go task as compared with healthy controls.  
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Method 
Participants 
 The initial sample consisted of 21 pediatric-onset relapsing remitting MS patients and 18 
healthy controls between the ages of 14 and 25. Patients were recruited from the Pediatric 
Demyelinating Clinic at the Hospital for Sick Children. Patients were informed about the study 
by letter, followed by a phone-call by a research assistant. Healthy controls were recruited from 
the Undergraduate Research Participant Pool (URPP) at York University and from local 
advertisements. Patients and controls were matched on sex and age (± 12 months), with the 
exception of one matched pair for whom the control was 21 months older than the matched 
patient. Another three patients were not matched with a control participant, but were included in 
the analysis to increase the sample size.  
The Research Ethics Board at York University and the Hospital for Sick Children 
approved the study. Participants older than 16 years provided informed consent, while younger 
participants gave verbal assent and their parents provided informed, written consent. 
Inclusion/Exclusion Criteria 
 Patients were clinically stable at the time of evaluation; all patients were less than 4 
weeks from any MS-related relapse or less than 4 weeks from corticosteroid treatment. 
Participants were excluded with the following criteria: (1) history of significant head trauma, as 
defined by a loss of consciousness for more than 5 minutes and a Glasgow scale score of less 
than 13; (2) history of alcohol or illicit drug use (greater than once per week, or use of cocaine, 
heroin or other illicit drugs); (3) best corrected visual acuity less than 20/100 in both eyes and 
self-reported red/green colour blindness; (4) hemiparesis of the dominant arm; (5) non-English 
speaking; (6) cognitive or behavioural disturbance which is considered to be severe enough to 
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preclude compliance with study procedures (disturbance may be secondary to a psychiatric 
disorder, such as ADHD). Patients with a history of a mood-related disorder (e.g. depression) 
were included since mood-related symptoms may be secondary to the MS disease process. 
Healthy control participants met the same inclusion and exclusion criteria, except those related to 
MS. 
General Procedure 
 Participants were first screened by telephone or, for patients, in clinic using a screening 
form (see Appendix 1) to ensure inclusion and exclusion criteria were met. Prior to testing, 
participants completed the MRI screening form to ensure they were safe to go inside the scanner.  
On the day of testing, participants completed questionnaires about demographics, mood, fatigue, 
as well as a 60-minute neuropsychological battery (see Table 1). Prior to scanning, participants 
were trained on the Go/No-go task (for 1 minute with 22 stimuli presented) to ensure 
understanding and comfort with the task demands.  Participants then underwent magnetic 
resonance imaging (MRI) using a 3.0 Tesla Siemens Tim Trio scanner at York University. The 
total time for MRI scanning was 70 minutes for healthy controls and 90 minutes for MS patients.    
Measures 
 Clinical-Demographic Information. All participants completed questionnaires about: 
(1) general health and demographic information using a Case History Form (see Appendix 2); (2) 
handedness using the Dutch Handedness Questionnaire (Van Stein, 1992); (3) mood using the 
Center for Epidemiologic Studies Depression Scale (CES-D) (Faulstich, Carey, Ruggiero, 
Enyart, & Gresham, 1986); and (4) fatigue on three dimensions (General, Cognitive, Sleep/Rest) 
using the Varni Pediatric Quality of Life (PedsQL) Multidimensional Fatigue Scale: Young adult 
self-report (ages 18-25) or Teen self-report (ages 13-18) (Varni, Seid, & Rode, 1999). Raw 
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scores were used for the CES-D and for each fatigue dimension and for total fatigue score on the 
PedsQL. An estimate of socioeconomic status was determined based on parental education and 
occupational status using the validated Barratt Simplified Measure of Social Status (Barratt, 
2006). For patients with MS, clinical information was obtained via chart review (or 
communication with their neurologist) regarding the following outcomes: age at disease onset 
(defined by age at first MS attack), total number of relapses, medication use, and physical 
disability as assessed by a neurologist using the Expanded Disability Status Scale (EDSS) 
(Kurtzke, 1983) within three months of this study.      
 Neuropsychological battery. All participants were evaluated with a battery of clinical 
neuropsychological tests that has been validated for detecting disease-related cognitive problems 
in childhood MS (see Table 1 for test battery and dependent variables). These measures were 
used to characterize the cognitive profile for the two groups and to compare cognitive 
functioning to performance on the Go/No-go task.  All of the neuropsychological data were 
analyzed after z transformation.  
 Full scale IQ was determined using the Wechsler Abbreviated Scales of Intelligence 
(WASI) two-subtest estimate (Wechsler, 1999). Attention and speed of processing were assessed 
using the Symbol Digit Modalities Test (SDMT) (oral version) (Smith, 1991), Woodcock 
Johnson (WJ-III) Decision Speed and Auditory Working Memory subtests (Woodcock, 
McGrew, & Mather, 2001), and the Trail Making Test (Parts A and B (Reitan, 1959). Verbal 
learning and memory were assessed using the Rey Auditory Verbal Learning test (RAVLT) 
(Lezak, 1983). The 9 Hole Peg Test (9HPT) (Mathiowetz, Weber, Kashman, & Volland, 1985) 
was used to examine fine motor dexterity and to rule out the possible confound of motor 
impairment on the Go/No-go task.  Norms for the 9HPT were taken from the National Institute 
of Health (NIH) normalization cohort (Wang et al., 2011).  These norms were chosen because 
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they are based on an age and sex-matched sample of large size that is similar to the participants 
in the present study.  Of note, the 9HPT was originally only administered to the patient group (to 
rule out motor impairment in the dominant hand) and hence data for the controls were not 
available. 
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Table 1  
List of cognitive and neuropsychological measures 
Domain   Measure  Dependent Measure            Estimated time 
  
 
Motor Function 9 Hole Peg Test  Time (z-score)  4 min 
Intellectual Function Wechsler Abbreviated Scales of 
Intelligence (WASI) – two 
subtest estimate of Full Scale IQ 
 
Vocabulary to assess general 
word knowledge; Matrix 
Reasoning to provide a 
measure of nonverbal 
conceptual reasoning (z-
score) 
10 min 
 
8 min 
 
Focused Attention and 
Cognitive Flexibility 
Trail Making Test – Parts A and 
B; WJ-III: Auditory Working 
Memory 
Time (z-score) 
Total score (z-score) 
5 min 
Speed of Processing  
 
Symbol Digits Modalities Test 
(SDMT: oral version); WJ-III: 
Decision speed 
Total score (z-score) 
Total score (z-score) 
2 min 
Learning & Memory Rey Auditory Verbal Learning 
Test (RAVLT) 
Total words recalled over 5 
trials (z-score) 
Short and long delay recall 
score (z-score) 
10 min 
Fatigue PedsQL – Multidimensional 
Fatigue Scale  
Young Adult Report (ages 
18-25); Teen Report (ages 
13-18) (raw score) 
4 min 
Family socioeconomic 
status (SES) 
The Barratt Simplified Measure 
of Social Status Measuring SES  
Level of school completed 
(for mother & father);  
Occupation (for mother & 
father) (total score) 
2 min 
Mood Center for Epidemiologic 
Studies Depression Scale (CES-
D) 
Total score (raw score) 4 min 
Handedness  The Dutch Handedness 
Questionnaire  
Total score for right, left, 
both hands 
3 min 
 
Note. The total time to complete all measures was 60 minutes. WJ-III = Woodcock-Johnson III. 
PedsQL= Varni Pediatric Quality of Life Multidimensional Fatigue Scale. 
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Go/No-go fMRI task 
 The Go/No-go task was programmed and run using E-prime (Psychological Software 
Tools, Pittsburg, PA, USA) on a Windows XP laptop. The program was originally developed by 
Mostofsky et al. (2003) and shared with our group for the current study. During the training 
period (outside the scanner), written instructions appeared on the computer screen and were read 
aloud by the research assistant. Participants were instructed to focus on the centre of the screen 
and push a button with their right index finger via a response keypad as quickly as possible when 
a green spaceship (Go stimulus) was presented on a black computer screen, but not when a red 
spaceship appeared (No-go stimulus) (see Figure 2A for sample stimuli). The spaceships were 
presented one at a time in a pseudo-random order over a brief, practice period (approximately 5 
minutes). Each trial consisted of a spaceship presented for 200 ms followed by a 1300 ms inter-
stimulus interval where a crosshair is displayed on the screen (see Figure 2B). The order of 
stimulus presentation favors a 5:1 green to red spaceship ratio in order to maximize the tendency 
for the participant to respond with a “go” button press. The following constraints were used: the 
red stimulus did not appear immediately after a rest interval or at data acquisition onset. When 
no stimulus was present, participants were asked to focus on the crosshair. Stimuli order did not 
differ across participants. 
The same instructions and procedures were followed inside the scanner. However, the 
length of the task was longer (8 minutes). During the test session and while in the scanner, 150 
trials were presented over 2 blocks, each consisting of 75 trials. Between each block, there was a 
brief rest interval lasting 20 seconds at which time three asterisks appeared on the screen and the 
participant was not required to make any motor response.  
 Performance parameters. The number of correct responses following stimulus 
presentation determined accuracy. A correct response was defined as a button press when a green 
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spaceship appeared (with a reaction time ranging between 200 to 460 milliseconds) and 
withholding a button press when a red spaceship appeared. A minimum accuracy rate of 75% 
correctly discriminated stimuli on the practice trial was accepted as an indication that the 
participant understood the task. A commission error was defined as a button response that 
occurred following the presentation of a red spaceship (No-go stimulus) or when a response was 
committed in less than 200 milliseconds following a go stimulus given that to make a basic 
perceptual decision and respond with a motor response it takes visual system and motor system 
around 200 milliseconds (Joubert, Rousselet, Fize, & Fabre-Thorpe, 2007). Omission error was 
defined as an absence of a button response following the presentation of the green spaceship (Go 
stimulus).  
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Figure 2. Schematic of Go/No-go paradigm.   
A. Task design.  B.  Example of presentation sequence.  C. Example of one ‘go’ trial. 
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MRI Procedures 
 Structural MRI Acquisition. Scans were carried out at the Neuroimaging Facility of the 
Center for Vision Research at York University on a Siemens 3.0 Tesla MAGNETOM Tim Trio 
scanner (Erlangen, German). Once in the scanner, participants viewed the task-related stimuli 
through a back projection screen (Avotec SV-6011) with angled mirrors mounted on a 32-
channel head coil. Participants responded to the tasks by pressing keys on a MRI compatible 
keypad (Current Designs, CA) with their index and middle fingers of their right hand. Foam 
padding was used to comfortably secure the participant’s head in the head-coil, and to minimize 
head motion during scans.  
A high-resolution structural volumetric image was acquired from all participants using a 
T1-weighted three-dimensional MPRAGE sequence (1 mm isotropic voxel size, TR=2300 ms, 
TE=2.96 ms). Proton density-weighted (TR=2200 ms, TE=10 ms, turbo factor=4) and T2-
weighted (TR=4500 ms, TE=83 ms, turbo factor=11) images were acquired for lesion 
segmentation using 2D turbo spin-echo sequences with 1x1x3 mm3 voxel size, along with a 
matching 2D turbo FLAIR sequence with TR=9000 ms, TE=88 ms, TI=2407.5 ms.   
 Lesion segmentation. All images were evaluated for adequate signal-to-noise ratio, 
freedom from significant motion or other artifact, and consistency of the sequence parameters. 
Image processing and structural MRI analyses were performed at the McConnell Brain Imaging 
Center by trained staff who were blind to clinical and behavioural data.  
 The following methods were used:  First, a preprocessing routine was run on all images 
to correct for intensity non-uniformity (Sled, Zijdenbos, & Evans, 1998), to remove skull and 
scalp (Smith, 2002) and to linearly register the T1-weighted images to the PD- and T2-weighted 
image to provide voxel-wise anatomical alignment across the modalities (Collins, Neelin, Peters, 
& Evans, 1994). Second, the intensity range was normalized within each image, using a two-
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piece linear transformation as described in Nyul & Udupa (1999). Third, using an interactive, 
mouse-driven visualization software package (DISPLAY, McConnell Brain Imaging Centre, 
Montreal Neurological Institute), the T2-weighted lesion labels output by an initial automated 
segmentation procedure (Francis, 2004) were superimposed on the T1-, T2-, and PD-weighted 
images, carefully reviewed and, if necessary, manually corrected. Given their different MRI 
intensity characteristics, infratentorial T2-weighted lesions were segmented manually. 
Hypointense regions on T1-weighted images (T1-weighted lesions) located within the T2-
weighted lesions were automatically segmented by applying an intensity threshold of 85% 
relative to the mean intensity of surrounding normal-appearing white matter. Supratentorial and 
infratentorial lesion volumes were combined as a measure of total brain lesion volume.  
 Brain and thalamus segmentation. Three standard preprocessing steps were applied to 
the native T1-weighted images to delineate whole brain and thalamus. These included: (1) 
removing noise by using the optimized non-local means filter (Coupe et al., 2008); (2) reducing 
the impact of intensity inhomogeneity due to RF coil variations using a non-parametric 
estimation of the slow varying non-uniformity field (Sled, Zijdenbos, & Evans, 1998), and (3) 
normalizing the brain volume intensities to the intensities of the target template [i.e., the 
ICBM152 population template (Fonov et al., 2011)] by doing regression based analyses on 
image intensity percentiles. The preprocessed T1-weighted images of each time point were then 
linearly registered to a subject-specific linear template created using the principles of unbiased 
average template construction as described in (Fonov et al., 2011). A hierarchical nine-parameter 
linear registration based on intensity cross-correlation as a similarity measure was performed 
between the subject-specific linear template and the ICBM152 population template (Collins, 
Neelin, Peters & Evans, 1994) to align the subject-specific template with the population template 
in stereotaxic space. 
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Native T1-weighted images were resampled once via the concatenated transformation from 
native space to the subject-specific template space, and from the subject-specific template space 
to the ICBM152 population template space. A multi-resolution non-local patch-based 
segmentation technique was used to extract the brain in the T1-weighted images resampled into 
the ICBM152 template space, using BEaST with a library of priors (Eskildsen et al., 2012). 
As T1-weighted images of each time point were also registered to a non-linear subject-specific 
template that was non-linearly registered to the population template (Collins et al., 1994), the 
thalamus label defined on the ICBM152 population template was warped back onto each time 
point’s T1-weighted images using the concatenated transformations, thus segmenting the 
thalamus in each scan for each subject.   
Functional MRI Acquisition 
Functional MRI images were acquired using a T2*-weighted echo planar imaging (EPI) 
sequence (TE=30 ms, flip angle=900, matrix size 86x64, FOV=258x192mm, TR=2s). Thirty-
four 4 mm thick axial slices acquired in transverse orientation allowed for coverage of the whole 
brain. 
Image Pre-processing and Data Analysis 
 Pre-processing and data analyses were performed using FSL software (Smith et al., 
2004). First, DICOM (Digital Imaging and Communications in Medicine) images were 
converted to NIFTI format (dicom2nitft). Second, non-brain tissue (skull and scalp) from the 
images of the whole brain was removed using Brain Extraction Tool (BET2) (Smith, 2002; 
Jenkinson, Pechaud, & Smith, 2005). Fourth, a first level analysis was carried out by 
constructing voxel-wise t-maps for each subject using the following steps: (a) Data: Each 
subject’s data contained 210 volumes with a TR of 2 seconds; 4 volumes were deleted from the 
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beginning of the run resulting in 206 volumes.  A high pass temporal filter cutoff of 60 seconds 
was implemented to remove low frequency artifact in each voxel’s time series.  (b) Pre-Stats: 
Spatial smoothing of the functional time series was done using a Gaussian filter (full width half 
maximum (FWHM) = 5 mm) to account for anatomic variability making the effective resolution 
coarser  This step is intended to reduce noise without reducing valid activation. (c) Stats: In this 
step, the general linear model that models the expected hemodynamic response was set up. FILM 
prewhitening was used to improve the linear model. FILM uses a robust and accurate 
nonparametric estimation of the time series autocorrelation to prewhiten each voxel’s time series, 
thus providing an improved estimation efficiency. Six standard motion parameters were also 
accounted for in the model (3 rotational (pitch, yaw, roll and 3 translational (x, y, z) motion 
parameters) in order to re-align all of the volumes to the first volume. The full model setup was 
used to account for the two explanatory variables (Go and No-go), though for the current study, 
only No-Go trials were modeled. The shape of each explanatory variable was accounted for by 
the onset time and the duration and this was convolved with the Double-Gamma Hemodynamic 
Response function (HRF).  Double-Gamma HRF attempts to match the difference between the 
stimulus waveform and the hemodynamic response function. A temporal derivative was added, 
which shifts the waveform slightly in time in order to achieve a better fit to the data by reducing 
unexplained noise and thus increasing power to detect statistical significance. A contrast (0,1) 
was set up to see which voxels showed any difference in BOLD response during presentation of 
a No-Go stimulus relative to baseline modeled in step c. (d) Post-Stats:  Significant activations 
were only provided for those values that were greater than threshold (cluster threshold, which 
corresponds to a Z threshold of 2.3 (p < 0.05)). (e) Registration: In order to summarize the 
location of activated voxels using coordinates from the MNI, the T1anatomical scan was 
incorporated and coregistered to the MNI152 1mm brain template using linear registrations 
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(12DOF). Finally, a third level analysis was conducted. Thirty-seven COPE images were 
inputted into the model. These are the images for the No-go response. Analyses involved 
between group (controls vs. patients), non-paired contrasts .In addition, healthy controls and 
patients were analyzed separately to examine within group activation. Significant activations 
were only provided for values that were greater than the cluster threshold (i.e. Z threshold of 2.3, 
p < 0.05). 
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Table 2   
Areas of activation for the No-go response on simple Go/No-go tasks as performed by healthy 
controls (Simmonds et al., 2008) and patients with MS (Bonnet et al., 2010)  
Participants   Brain Region     Hem. BA 
 
Healthy Controls  Inferior occipital gyrus   R 19 
    Fusiform gyrus/posterior cerebellum  L 19/37 
    Superior medial wall (pre-SMA)  R 6/32 
    Precuneus     R 7   
Patients with MS  Cingulate gyrus    R 31 
    Cerebellum Hemisphere   R - 
    Temporo-occipital    R - 
    Cingulate gyrus    R 24 
    Temporal gyrus    R 21/22 
    Medial frontal gyrus    L 9   
Note: Hem.=Hemispheres, B=Bilateral; BA = Brodmann Area; SMA =  Supplementary Motor 
Area.  
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Statistical Analysis 
 The Kolmogorov-Smirnov and Levene’s tests were used to assess for any violations of 
normality and homogeneity of variance within data sets.  Groups were compared on 
demographic (age, sex, socioeconomic status, fatigue, mood) and neuropsychological variables 
using independent t-tests or Mann-Whitney U tests, where appropriate. In the absence of a 
normal distribution, nonparametric tests were used. Cognitive impairment was determined if 
participants scored below 1.5 standard deviations on at least 2 of 8 tests. The tests included: (1) 
WASI Matrix Reasoning; (2) WASI Vocabulary, (3) Trail Making Part A and B; (4) WJ-III 
Auditory Memory; (5) SDMT; (6) WJ-III Decision Making; and (7) RAVLT (total learning). All 
behavioural analyses were performed using SPSS 20 (IBM, 2011). A conservative alpha of 0.01 
was used to assess significance in the between-group analysis of the cognitive data because of 
multiple comparisons involved; for all other analyses, an alpha of 0.05 was used. 
 Go/No-go task analysis (Objectives 1 and 2). The primary dependent variables for this 
task included accuracy (proportion correct across total go and no-go trials) and reaction time 
(RT). Reaction time below 200 ms was removed from the calculation of mean RT as a response 
below this threshold was considered a commission error. Likewise, a failure to respond to a 
target (i.e. an omission error) was not included in the calculation of mean RT. Secondary 
dependent variables included total number of commission (unsuccessful inhibition of response) 
and omission errors (required response not given to a Go stimulus). To assess differences 
between groups on the Go/No-go task, one-way analysis of variance and Kruskal-Wallis test 
were performed on each dependent variable. Pearson correlations (one-tailed) were used to 
assess the inter-relations between accuracy and RT on the Go/No-go task and clinical-
demographic variables (age at assessment, age at disease onset, duration of disease, fatigue 
score, and depression score), and MRI variables (brain volume and thalamic volume, log-
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transformed T2- and T1-weighted lesion volume).  The relationship between age at disease onset 
and Go/No-go performance was examined after controlling for disease duration as to not 
confound younger age at disease onset with a longer disease duration. Note that T1- and T2-
weighted lesion volumes were log transformed given the positively skewed distribution of these 
data.  Spearman rank correlations were used for CES-D Depression total and PedsQL total 
fatigue scores given the non-normal distribution of these variables.  
 Functional MRI data analysis (Objective 3).  A mixed effects: FLAME1 higher level 
modeling will be used to contrast voxels between patients and controls. This method uses 
Bayesian modeling and estimation. FLAME1 provides the most accurate estimation of 
activation. First, the higher-level model is fit and approximations are made regarding the 
activations. Then, all voxels that are close to threshold are processed using Mixed Effects 
variance (Metropolis-Hastings Markov Chain Monte Carlo sampling) to give a distribution for 
higher-level contrasts of parameter estimates, to which a general t-distribution is then fit.  
Functional whole brain activation data in response to the No-go stimulus was examined using 
FSLview (Smith et al., 2004). Activation patterns were defined for both groups as well as 
between groups for the No-go trials using Talairach Daemon function.  
Group Characterization 
 From the initial sample of 18 control participants, one participant was excluded because 
of extreme motion artifact on the images due to repeated removal from the scanner as a result of 
discomfort, and very low performance outcomes on all cognitive measures that fell outside the 
normal range expected for control participants. From the original sample of 21 patients, one 
participant was removed  due to technical error in acquiring behavioural data during the GNG 
task.  Thus, clinical and neuroimaging data were available for 17 controls and 20 patients. 
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 Demographic Information. As shown in Table 3, the healthy control group ranged in 
age from 14.92 - 24.33 years (M = 19.26, SD = 2.63) and the patient group ranged in age from 
13.17 - 24.25 years (M = 19.36, SD= 2.99).  There were no differences in age, social economic 
status, and in years of education. Both groups showed right hand dominance with 94% controls 
(n = 16) and 85% patients (n = 17) classified as right hand dominant. Seventy-six percent of 
controls (n = 13) and 70% of patients (n = 14) were female, consistent with the female sex 
predominance in MS post-puberty. 
 Clinical Features of the MS Group. The average age at disease onset (defined by date 
of first attack) was 13.60 ± 2.58 years of age (range: 10 - 19 years). The average disease duration 
was 5.07 ± 3.10 years, with a range of 1.10 - 10.92 years. The total number of relapses 
documented in the patient health records ranged from 1 to 10 with a median score of 3 relapses; 
only 7 patients experienced 5 relapses or more. Sixteen of 20 (80%) patients were receiving 
disease-modifying treatment at time of evaluation. Treatments included: Copaxone (n=6, 30%); 
Tysabri (n=3, 15%), Fingolimod (n=2, 10%); and interferon-beta: Avonex (n = 4, 20%); 
Betaseron (n = 1, 5%). The majority of patients (17/20; 85%) had a low grade of disability as 
characterized by an EDSS score below 3 (Mdn = 1.5, range: 1.0-6.0); only 3 of 20 patients (15%) 
had an EDSS score above 3 (which is still indicative of mild disability), and none of them 
required ambulatory aid and all had normal functioning of the right upper limb. 
 As shown in Table 3, mood as assessed by the CES-D scale, did not differ between the 
two groups using mean symptom count score. Mild symptoms of depression (as classified by a 
score between 16-26 points on the CES-D were reported by 4 controls and 3 patients, whereas 
more elevated symptoms of depression (classified by a score above 27 points) were reported by 1 
control and 5 patients. The MS group did not report more fatigue symptoms on the Total Fatigue 
scale as compared with controls. Fatigue symptoms did not differ between groups on any of the 
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individual fatigue scales of the Varni PedsQL (General Fatigue, Cognitive Fatigue and 
Sleep/Rest Fatigue scales), however General Fatigue scale was slightly higher in the MS group 
and approached significance (p < 0.10). 
 Structural MRI Measures. As shown in Table 4, controls and patients significantly 
differed with respect to normalized brain volume (p = 0.003). Thalamic volume approached 
significance (p = .06) with a larger volume in the controls relative to the patients. In the patient 
sample, the T2- and T1-weighted lesion volumes were log transformed as a result of outliers that 
skewed the data in a positive direction. For patients, mean log T2-weighted lesion volume was 
0.95 ± 0.21 cm3 with a range of 0 to 2.01 cm3 and mean log T1-weighted lesion volume was 0.58 
± 0.13 cm3 with a range of 0 to 1.87 cm3 
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Table 3   
Clinical and demographic information for healthy controls and patients with MS. 
Measure    Healthy Controls Patients       p value 
       
     n=17   n=20                    
Mean age (years)   19.26 (2.63)  19.36 (2.99)  0.91   
Handedness (N, %R)   16 (94%)  17 (85%)  0.37† 
Social Economic Status  38.39 (14.40)   44.85 (14.59)  0.20*    
Sex (N, %F)    13 (76%)  14 (70%)  0.66   
Education (years)   13.18 (2.10)  13.2 (2.71)  0.97  
Depression Score (CES-D)  12.35 (7.83)  16.55 (14.43)  0.73* 
PedsQL-Total Score    23.59 (8.47)  30.35 (13.83)  0.17*  
PedsQL-General Fatigue  6.82 (3.83)  9.50 (5.34)  0.09   
PedsQL-Cognitive Fatigue  7.94 (3.79)  10.00 (5.86)  0.22*   
PedsQL-Sleep/Rest Fatigue  9.47 (3.48)  10.85 (3.96)  0.27   
Note. R = right handed; F = female; MS = multiple sclerosis; CES-D = Centre for 
Epidemiological Studies Depression Scale; PedsQL= Multidimensional Fatigue Scale. P values 
represent group differences using t-tests, *Mann-Whitney U tests, or †Chi-square analysis. Data 
are reported as mean and standard deviation, except where indicated.  
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Table 4   
MRI measures for healthy controls and pediatric-onset MS patients 
 
Measure    Healthy Controls Patients       p value 
       
     n=17   n=20  
          
Normalized Brain volume (cm3) 1614.09 (75.57) 1546.47 (52.79) 0.003  
Thalamic volume (cm3)  12.57 (1.12)  11.79 (1.31)  0.06   
Log T2-weighted LV (cm3)  -   0.55 (0.95)  - 
Log T1-weighted LV (cm3)   -   0.47 (0.58)  -   
Note. All data are reported as mean and standard deviation (M(SD)). LV = lesion volume.  
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 Cognitive measures.  Table 5 summarizes the cognitive measures for controls and 
patients. No significant difference was found in intellectual functioning between groups as 
measured by WASI Full scale IQ. Scores for controls and patients range from 81-124 and 78-
129, respectively. Moreover, there were no statistical differences between groups on any of the 
specific cognitive measures included in the battery. Two patients and two controls met criteria 
for cognitive impairment using the pre-determined criterion of falling below 1.5 standard 
deviations on 2 of 8 measures in the screening battery. Importantly, the correlation between 
reaction time on the Go/No-go and z-score on 9HPT was not significant in the MS group (r = -
0.127, p = 0.59), suggesting reduced fine motor dexterity on the 9HPT task was not associated 
with response speed on the Go/No-go task.  
 In summary, controls and patients did not differ in terms of demographic, clinical, 
cognitive and behavioural characteristics. Regarding the MRI variables, patients showed lower 
brain volume (p<.01) and thalamic volume (p=0.06) as compared with the control group.  
 
 
 
 
 
 
 
 
 
 
44 
 
 
Table 5   
Cognitive outcomes (Mean and SD) for healthy controls and pediatric-onset MS patients 
Measure   Healthy controls Patients with MS Per cent p 
          < 1.5 SD 
    n=17   n=20   HC MS 
WASI-Full-2 IQ†  0.40 (0.78)  0.32 (0.75)  0 0 0.77 
WASI Matrix Reasoning† .41 (0.55)  0.22 (0.80)  0 1 0.47 
WASI Vocabulary†  0.39 (0.69)  0.35 (0.86)  0 1 0.87 
Trail Making Test-Part A† 0.49 (0.78)  0.41 (0.68)  0 0 0.74  
Trail Making Test-Part B † -0.09 (1.26)  0.24 (1.87)  11.76 15 0.81*  
WJ-Decision Speed†  0.05 (1.23)  -0.09 (0.85)  5.88 5 0.70  
WJ-Auditory Memory † 0.36 (0.63)  0.44 (0.51)  0 0 0.71  
SDMT†   0.21 (1.25)  0.56 (1.38)  0 10 0.31* 
RAVLT-total learning† -0.56 (1.30)  -0.04 (1.21)  25.53 10 0.21  
RAVLT-short delay  -0.73 (1.86)  -0.55 (2.35)  23.53 20 0.40* 
RAVLT-long delay  -0.21 (1.14)  0.49 (3.35)  11.76 20 0.94*  
9HPT-dominant**  -   -1.71 (1.99)  - 45 - 
9HPT-nondominant** -   -1.59 (1.84)  - 50 - 
Note: SDMT = Symbol Digit Modalities Test; RAVLT = Rey Auditory Verbal Learning Test; 
9HPT = 9 Hole Peg Test. All measures are reported as z-scores. *Mann-Whitney U tests were 
used to compare groups. All other data are analyzed using independent t-tests.  Data are reported 
as mean and standard deviation. **Indicates that data is only available for 19 patients. † Indicates 
the measures used in the criterion for defining cognitive impairment, i.e. 2 of 8 failed tests. 
WASI-Full-2-IQ is comprised of two subtests: Vocabulary and Matrix Reasoning. 
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Behavioural data on the Go/No-go task (Objective 1) and the influence of age at disease 
onset and cerebral tissue damage on Go/No-go performance parameters (Objective 2). 
Table 6 summarizes the behavioural performance on the Go/No-go task for the controls 
and patients. All participants scored above the minimum 75% accuracy rate on the Go/No-go 
task. Groups did not differ with respect to RT and accuracy on the Go/No-go.  Accuracy ranged 
from 92% to 100% for controls and 91% to 99% for patients. Although mean RT was slightly 
longer for patients than controls, the difference was not significant. Likewise, there was no 
difference in number of commission and omission errors.  The total number of commission 
errors made by controls ranged from 1-15 (median score = 9) and the total number of 
commission errors made by patients ranged from 2-16 (median score = 4.5). The total number of 
omission errors made by controls ranged from 0-7 (median score = 0) and by patients ranged 
from 0-14 (median score = 0). In order to examine the possibility of increased variability in RT 
over the duration of the task (which may occur due to increased fatigue over the task), a repeated 
measures ANOVA was used to compare RT on Block 1 to Block 2 in patients and controls. 
Results revealed no main effect of block (F(1, 1) = 0.32, p =0.57) or an interaction between 
block and group (F (1, 1) = 0.33, p =0.57).  
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Table 6   
Behavioural data for Go/No-go task 
 
Measure   Healthy Controls Patients       Group difference 
       
    n=17   n=20          p         Partial η2 
   
Reaction Time (ms)  333.70 (41.04)  358.85 (54.42)  0.13 0.065  
Accuracy (% correct)  96.48 (2.08)  96.61 (2.67)  0.87 0.001 
Commission Errors*  9 (1-15)  4.5 (2-16)  0.39 0.021   
Omission Errors*  0 (0-7)   0 (0-14)  0.35 0.026  
Note. Reaction time was only reported for correct responses greater than 200 ms; Data reported 
as mean and standard deviation except where indicated. *Mann-Whitney tests were used and 
median scores and ranges are reported.   
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Table 7 and 8 show the correlations between the Go/No-go behavioural outcomes and 
demographic, clinical, and MRI correlates for patients and controls.  Age at evaluation did not 
correlate with performance parameters, nor did measures of fatigue, depression symptoms, and 
fine motor dexterity on the 9HPT. Regarding clinical variables, younger age at disease onset 
(controlling for disease duration) was associated with lower accuracy (r = 0.38), and this 
difference approached significance (p (one-tailed) = 0.054) (See Figure 3).  Closer examination 
of this relationship revealed that patients with younger disease onset made more commission 
errors.  Age at disease onset was not associated with reaction time (r = 0.31, p (one-tailed) = 
0.10).  
Regarding MRI correlates, patients did not show a significant relationship between 
normalized brain volume and thalamic volume with accuracy or reaction time on the Go/No-go 
task.  Regarding lesion volume in the patient group, poorer performance on the GNG task 
approached significance with higher T1-weighted lesion volume (r = -0.32, p = 0.09). Regarding 
the control group, poorer reaction time on the GNG task was significantly correlated with lower 
thalamic volume (r = - 0.702, p = 0.001).  
In summary, controls and patients performed similarly on the Go/No-go task in terms of 
all behavioural measures. Age at evaluation, fatigue, depression symptoms, and fine motor 
dexterity on the 9HPT did not correlate with performance parameters. Younger age at disease 
onset (controlling for disease duration) was associated with lower accuracy (at a trend level), 
revealing that patients with younger disease onset made more commission errors as compared 
with patients who were older at time of disease onset. Higher T1-weighted lesion volume was 
also marginally associated with lower accuracy. Longer reaction time associated with lower 
thalamic volume in the control group, but not the patient group (See Figure 4). 
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Table 7   
Correlations Between Go/No-go Behavioural Outcomes and Clinical-Demographic and MRI 
Outcomes for the MS Group  
Variable                     Go/No-go Outcome 
 
         RT  Accuracy 
 
 
Age at assessment       0.37  0.33 
Age at disease onset†       0.31  0.38 
Duration of disease       0.34  0.13 
PedsQL Total Fatigue Score*      0.17  0.11 
CES-D Depression Total Score*     0.20  0.18  
9 Hold Peg Test (9HPT)-Dominant hand* (z-score)             -0.14            -0.05 
Normalized Brain volume      0.062            0.096 
Thalamic brain volume                -0.098  0.243 
Log T2-weighted LV       0.03            -0.23  
Log T1-weighted LV       0.25            -0.32   
Note. Pearson correlations used (one-tailed), expect where a * is indicated for which Spearman’s 
correlation was used. † Controlling for disease duration. Bolded values indicate p < 0.10. 
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Table 8   
Correlations Between Go/No-go Behavioural Outcomes and Clinical-Demographic and MRI 
Outcomes for the Healthy Controls 
 Variable                     Go/No-go Outcome 
         RT  Accuracy 
Age at assessment       -0.41  -0.14 
PedsQL Total Fatigue Score*      -0.002  -0.03 
CES-D Depression Total Score*       0.10  -0.09 
9 Hold Peg Test (9HPT)-Dominant hand* (z-score)    0.36   0.1 
Normalized Brain volume      -0.096   0.29 
Thalamic volume       -0.702   0.079 
Note. * Indicates Spearman’s correlation one-tailed test used (p < 0.05). If not indicated Pearson 
correlation one-tailed test used.  Bolded values indicate p < 0.05 
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Figure 3. A.  Correlation between reaction time and age at disease onset (controlling for disease 
duration) for MS group.  B. Correlation between accuracy and age at disease onset (controlling 
for disease duration) for MS group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Reaction Time B. Accuracy 
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Figure 4.  A. Correlation between reaction time and thalamic volume for controls. B. Correlation 
between reaction time and thalamic for patients.  
 
 
 
 
 
 
 
 
 
 
 
 
A. Controls                                                 B.  MS group 
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Functional MRI data analysis of the No-go stimuli (Objective 3) 
 Activation patterns were reported for each group separately and then were compared to 
one another. Only significant activation patters were identified using a cluster threshold of Z > 
2.3 (p < 0.05).  As shown in Figure 5, healthy controls showed significant activation in diffuse 
brain regions, including (1) bilaterally in the anterior cingulate gyrus, cerebellum, frontal lobe, 
inferior frontal gyrus, medial frontal gyrus, superior frontal gyrus, posterior cingulate gyrus, 
bilateral parietal lobe (2) right hemisphere: precuneus, temporal lobe; and in the (3) left 
hemisphere: inferior occipital gyrus, occipital lobe, superior temporal lobe (Table 95). The same 
contrast in patients showed a less extensive pattern of threshold activation.  As shown in Figure 
6, patients showed significant activation in the (1) right hemisphere:  precuneus, middle frontal 
gyrus, parietal lobe and superior frontal gyrus; and (2) left hemisphere: middle temporal and 
inferior temporal gyrus, and fusiform gyrus (Table 10). When patients and controls were 
examined for between group differences, healthy controls showed more activation than patients 
in the following regions: (1) bilaterally in the cerebellum and precentral gyrus; (2) the right 
hemisphere: precuneus and lateral occipital cortex; (3) left hemisphere: brainstem, superior 
frontal gyrus and parahippocampal gyrus (Table 11, Figure 7). Patients did not show more 
activation than controls in any region.  
In summary, controls exhibited more extensive brain activation patterns than patients in 
response to the No-go stimulus on the GNG task (Table 12). Surprisingly, posterior regions of 
the brain (cerebellum, precuneus, occipital cortex, brainstem) as well as the superior frontal 
gyrus and the parahippocampal gyrus were recruited to a greater extent in the controls compared 
with the patient group. 
 
 
53 
 
Table 9    
Regions of interest activated by controls during No-go trials 
Region/gyrus    Hem.          Talairach Coordinates      Z     Cluster Size 
       x y z        (Voxels) 
Frontal Lobe    R  13 36 -4 2.57      77 
Frontal Lobe    L  -45 48 -3 3.04      38 
Superior Frontal Gyrus  R  19 22 48 3.64  1333 
Superior Frontal Gyrus  L  -24 34 48 3.03      25 
Inferior Frontal Gyrus   R  58 10 27 3.04      58 
Inferior Frontal Gyrus   L  -52 19 16 4.18             8792 
Medial Frontal Gyrus   R  10 49 37 3.63  2314 
Medial Frontal Gyrus   L  -15 58 -4 3.10    312 
Middle Frontal Gyrus   R  44 16 45 4.16  1851 
Parietal Lobe/Cingulate Gyrus R  4 -40 33  4.78          60848  
Superior Parietal Lobe  L  6 -71 50 2.50      1 
Precuneus    R  14 -55 53 2.54      50 
Posterior Cingulate Gyrus  R  45 -16 49 3.65  5507 
Anterior Cingulate    R  8 57 -9 3.59    449 
Anterior Cingulate   L  -11 34 -10 3.11    432 
Middle Temporal Gyrus  L  -54 -55 -8 4.20             8424 
Temporal Lobe   R  47 -10 -18 4.26  3895 
Occipital Lobe   L  -4 -85 38 3.05                 14 
Inferior Occipital Gyrus  L  -30 -90 -12 2.52      55 
Posterior Cerebellum   L  -53 -58 -20 3.03      31 
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Cerebellum    R  16 -74 -28 4.23             5853 
Note. L=Left, R=Right. Volume per voxel 2.997 x 2.997 x 4=35.93mm3. x,y,z are peak of mass 
coordinates for each cluster. Significant activation (p<0.05, Z > 2.5 Threshold Cluster) 
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Figure 5. Brain regions showing significant activation (p<0.05, Z >2.3 Threshold Cluster) to No-
go stimuli for controls. Axial slices are in radiological convention (left hemisphere is on the 
right). The bar on the right indicates activations based on z-score.  
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Table 10   
Regions of interest activated by MS patients during No-go trials 
Region/gyrus    Hem.  Talairach Coordinates      Z     Cluster Size 
           x y z     (Voxel Size) 
Superior Frontal Gyrus  R  44 21 50     2.99        21 
Middle Frontal Gyrus   R  46 28 26     4.18             6904 
Precuneus    R  12 -48 39     4.77           11138 
Parietal Lobe    R  41 -65 36     4.79  5496 
Middle Temporal Gyrus  L  -37 -73 30     4.77   4457 
Interior Temporal Gyrus  L  -64 -51 -7     3.03      24  
Fusiform Gyrus   L  -48 -55 -19     2.5        2 
Note. B=Bilateral. L=Left, R=Right. Volume per voxel 2.997 x 2.997 x 4=35.93mm3. x,y,z are 
peak of mass coordinates for each cluster. Significant activation (p<0.05, Z > 2.3 Threshold 
Cluster) 
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Figure 6.  Brain regions showing significant activation (p<0.05, Z > 2.3 Threshold Cluster) to 
No-go stimuli for pediatric-onset MS patients. Axial slices are in radiological convention (left 
hemisphere is on the right)  
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Table 11   
Regions showing greater cerebral activation by controls compared to patients during No-go 
Trials 
Region/gyrus   Hem.  Talairach Coordinates       Z      Cluster size 
         x y z           (Voxels) 
Superior Frontal Gyrus L  -22 -8 74  4.10     667  
Precentral Gyrus/SMA R  4 -16 72  3.58     534 
Precentral Gyrus  L  -35 -13 70  2.99      38 
Superior Parietal Lobe R  33 -48 64  2.50        1 
Precuneus   R  13 -58 58  3.07     354 
Parahippocampal Gyrus L  -27 -27 -27  3.05        7 
Lateral Occipital Cortex R  27 -65 66  3.48     401  
Posterior Cerebellum  L  1 -63 -5  2.50                   1 
Cerebellum   R  18 -55 -29  3.13       8382 
Brainstem-midbrain  L  -14 -20 -11  3.70   4504 
Note. B=both. L=Left, R=Right. Volume per voxel 2.997 x 2.997 x 4=35.93mm3. x,y,z are centre 
of mass. MS=patients with MS, Con= controls. Significant activation (p<0.05, Z > 2.3 Threshold 
Cluster). 
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Figure 7. Brain regions showing significant response (p<0.05, Z > 2.3 Threshold Cluster) to No-
go stimuli for Controls compared to patients. Patients did not show greater significant activations 
patterns than controls. Axial slices are in radiological convention (left hemisphere is on the 
right).  
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Table 12   
Between group differences in brain activation patterns between patients and controls. 
Brain Region Hem. Controls MS Controls>MS 
          
Frontal Lobe Bil. X     
Superior Frontal Gyrus L X     
Superior Frontal Gyrus R X X X 
Inferior Frontal Gyrus  Bil. X     
Medial Frontal Gyrus Bil. X     
Middle Frontal Gyrus R X X   
Precentral Gyrus Bil.     X 
          
Parietal Lobe R X X   
Superior Parietal Lobe L X   X 
Precuneus R X X X 
          
Posterior Cingulate Gyrus Bil. X     
Anterior Cingulate Gyrus Bil. X     
Parahippocampal L     X 
Fusiform R   X   
          
Temporal Lobe R X     
Inferior Temporal Gyrus L   X   
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Middle Temporal Gyrus L X X   
          
Occipital Lobe L X     
Inferior Occipital Gyrus L X     
Lateral Occipital cortex R     X 
          
Cerebellum R X   X 
posterior cerebellum L X     
Brainstem-midbrain L X     
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Discussion 
 The present investigation had three aims.  First, the simple Go/No-go task was used to 
examine response inhibition in patients with pediatric-onset MS and age-and-sex matched 
controls. As with previous neuropsychological literature (Till et al., 2012), cognitively intact 
pediatric-onset patients with MS were not expected to demonstrate difficulties with performance 
on the task because response inhibition is rarely compromised in comparison to other executive 
functioning tasks. Second, the Go/No-go performance parameters were used to evaluate the 
association of age at disease onset and cerebral tissue damage. Literature shows that attentional 
control and response inhibition networks develop throughout childhood, which places patients 
with a younger age at disease onset at risk of poorer performance on a task of response 
inhibition. Likewise, the literature reports that higher levels of cerebral tissue damage (as 
indicated using structural MRI) predict poorer performance on the simple Go/No-go task. The 
final aim was to examine the pattern of cerebral activation produced by childhood-onset MS 
patients compared to healthy controls. Studies conducted in adults with MS (Bonnet et al., 2010) 
as well as adolescents with MS (Rocca et al., 2003) show recruitment of supplementary cerebral 
areas, in addition to expected brain regions, in order to perform as well as healthy controls.  
In the present study, two main findings are reported: (1) pediatric-onset MS patients who 
are cognitively intact perform equally well as controls on a simple task of response inhibition 
(Go/No-go); and, contrary to our hypothesis, (2) a  less extensive brain activation is 
demonstrated by pediatric-onset MS patients when performing a task requiring response 
inhibition as compared with the age-matched controls.  While none of the clinical and MRI 
variables correlated significantly with Go/No-go task performance in the patient sample, two 
interesting relationships emerged that were consistent with the hypothesis and therefore warrant 
further discussion.  First, better performance on the Go/No-go task was associated at a trend 
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level (p = 0.054) with older age at disease onset, supporting an early vulnerability perspective.  
Second, higher lesion volume was associated with lower accuracy, again at a level that 
approached significance (p < 0.10).  These findings will be discussed in more detail below.   
Objective 1: To examine response inhibition in patients and age-matched controls using a 
simple Go/No-go task   
As hypothesized, cognitively intact pediatric-onset patients did not demonstrate 
significant deficits on the simple Go/No-go task with respect to accuracy and reaction time.  This 
finding was expected given the clinico-demographic characteristics of the patient group 
evaluated in the current study.  Specifically, in terms of demographic features, both patients and 
controls were similar in terms of age, education, and social economic status, thus ruling out the 
possibility of better performance on the GNG task due to maturational or socio-demographic 
differences. In terms of clinical features, both groups were similar in terms of mood as assessed 
by the CES-D, and fatigue symptoms as measured by Varni PedsQL (general fatigue, cognitive 
and sleep/rest scales). This is important because both depression and fatigue may reduce speed of 
processing (Diamond, Johnson, Kaufman, & Graves, 2008), which in turn, would have 
influenced performance on the GNG task. Elevated depression and physical fatigue scores have 
been found to mediate the strength of the relationship between processing speed and cognitive 
tasks that require learning and memory. Moreover, the possibility that the patients showed 
‘increased fatigue’ over the length of the GNG task was ruled out by examining changes in RT 
that occurred between block 1 and block 2 of the task.  Results showed that both patients and 
controls performed similarly (measured by RT and accuracy) across the two blocks. This 
suggests that patients maintained their RT over the length of the relatively simple GNG task.  
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 Most importantly, the MS group performed similarly to controls across all cognitive 
tests. Both groups were very similar to one another cognitively, even with respect to the number 
of participants meeting criteria for cognitive impairment in each group. This is important because 
it permitted a comparison of the functional activations in the brain regions using a well-matched 
control group. Previous literature (Loitfelder et al., 2011) has shown that cognitively impaired 
patients show different patterns of activation and thus the results to objective 3 would be much 
different if the group was a more heterogeneous sample that included more patients with 
cognitive impairment.  
In comparison to previous studies that report cognitive impairment in pediatric-onset MS 
patients (Amato et al., 2008; Banwell & Anderson, 2005; MacAllister et al., 2005; Till et al., 
2011), our sample of patients performed similarly to controls and showed minimal deficits on the 
cognitive screening battery. Thus, there was no reason to suspect that the patient group would 
have difficulty on the simple Go/No-go task in terms of accuracy and reaction time. In contrast, 
if the Go/No-go task used a more complex version, as done in previous studies (Bonnet et al., 
2010), a significant difference between patients and controls would be expected to occur with 
respect to both performance parameters (reaction time), as well as cerebral activations. With 
higher cognitive demands (as seen in the complex Go/No-go condition), there is an increased 
cognitive load and recruitment of extra regions that become saturated in patients with MS. 
Despite greater activation, patients perform worse than controls (Bonnet et al., 2010). In the case 
where patients and controls performed differently on the task from one another, it would be 
difficult to conclude whether the supplementary areas aided performance.  
Despite reduced fine motor dexterity (as indicated by a low mean score on the 9 Hole Peg 
Test (9HPT), patients did not show slower reaction time on the Go/No-go task.  The lack of 
association between the 9HPT and the functional MRI task (r = -0.14) may be explained by the 
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fact that the simple button response for the Go/No-go task does not require fine motor dexterity 
(i.e. it is not as complex a motor movement as picking up a small peg and placing it into a hole 
quickly).   
In summary, performance was similar for controls and patients across cognitive tasks, 
with two patients and two controls classified as cognitively impaired. Likewise, performance on 
the Go/No-go task was similar for both groups and consistent with the previous adult MS 
literature demonstrating intact inhibitory control using similar Go/No-go paradigms (e.g. Bonnet 
et al., 2010; Smith et al., 2009).  
Objective 2.  To evaluate the influence of age at disease onset and cerebral tissue damage 
on Go/No-go performance parameters 
It was hypothesized that younger age at disease onset would result in worse performance 
on the Go/No-go task.  Results of the current study showed a trend between younger disease 
onset (controlling for duration of disease) and lower accuracy (r = 0.38, p = 0.054). Inspection of 
the types of errors made by patients indicated that commission errors were more common in the 
young disease onset patients. This finding was irrespective of age, as age at evaluation did not 
show a correlation with performance parameters. The current findings are consistent with those 
reported by Till et al. (2012) showing a significant association between younger age at onset and 
inhibitory control as assessed using the Colour-Word Interference tests on the Delis-Kaplan 
Executive Function Scale (DKEFS). Other studies in pediatric-onset MS (Banwell & Anderson, 
2005; MacAllister et al., 2005) have also related younger age at disease onset with difficulties on 
tasks that require self-generated organizational strategies, efficient processing speed or working 
memory, all of which are executive functions.  The findings are also concordant with prior 
research conducted in children with traumatic brain injury showing that both pre-injury ability 
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and age at injury are both significant predictors of executive functioning skills (Anderson & 
Catroppa, 2005; Anderson et al., 2008).  Taken together, these findings emphasize age at disease 
onset as a predictor of executive dysfunction and implicate the vulnerability of immature neural 
networks.  
The present results suggest a greater vulnerability of the immature brain and refute the 
Kennard principle which states that the immature brain is more plastic and less vulnerable to 
insult than a mature brain (Montour-Proulx et al., 2004). A study (Duval et al., 2008) examining 
the relationship between time of brain insult and IQ outcomes in 725 patients who ranged in age 
from 0 to 84 years found that those who suffered the brain insult in childhood had lower IQ 
scores and a deterioration in IQ over time whereas the adult-onset group’s IQ did not show 
deterioration. These results highlight the vulnerability of the immature brain. In another study, 
Crowe, Catroppa, Babl and Anderson (2013) examined inhibitory control, attentional control and 
information processing in three to six year old children who sustained a mild to moderate-severe 
traumatic brain injury (TBI) before 3 years of age compared to healthy age-matched controls. On 
a task of inhibitory control (NEPSY-II Statue subtest), children who had a TBI prior to age 3 
performed significantly worse than healthy children. Inhibitory control begins to develop prior to 
this age therefore it is not surprising that insult would interfere with proper development of 
inhibitory control. The study found no difference in performance on tasks of auditory attention 
(examining selective attention and vigilance) and information processing (examined using 
WPPSI-III Coding subtest) between the two groups (Crowe et al., 2013).  Decreases in attention 
and information processing may not have been seen since both of these executive functioning 
skills continue to develop after age 6 and may only become apparent deficits over time as 
environmental demands increase (Crowe et al., 2013).  
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After children sustain a brain injury they must not only recover the affected functions but 
they must also acquire new skills. The rate of acquiring new skills in these children, however, 
may be restricted by of the brain insult, causing children to fall even more behind same-aged 
peers (Duval et al., 2008). Cognitive impairment was examined at two time points, 3 months and 
30 months after insult (Anderson et al, 2005). At 3 months after injury, children who experienced 
insult between birth and 12 years of age had similar levels of impairment. However, when these 
same children were examined at 30 months post insult, children who acquired insult prior to age 
7 had a slower recovery and performed worse than children who acquired insult later (12 years of 
age). These findings suggest that deficits acquired earlier may become more pronounced with 
time and may emerge as a result of increased environmental demands (Anderson et al. 2005).  
Inhibitory control appears to be one of the first executive functions to develop and mature 
as reflected through age-dependent change in brain activations required to effectively exhibit 
inhibitory control. In an fMRI study (Marsh et al., 2006), the Stroop interference task was used 
to examine inhibitory control in 70 healthy individuals between the ages of 7 to 57 years of age.  
Results revealed a positive relationship between activation of the right inferolateral prefrontal 
cortex (BA44/45) and right lenticular nucleus with age. Greater activity in the right inferolateral 
prefrontal cortex was also accompanied by better inhibitory control, as measured by accuracy 
rate (Marsh et al., 2006). There was also deactivation in the mesial prefrontal cortex (BA10), 
subgenual anterior cingulate cortex (BA 24), and posterior cingulate cortex (BA 31) with 
increased age, which corresponded with a decrease in task difficulty in older subjects (Marsh et 
al., 2006). Insults that occur during critical periods of executive function development may result 
in abnormal development of neural networks that underlie these executive skills.  
The extent of brain injury severity and location of brain insult (Duval et al., 2008; Crowe, 
Catroppa, Babl, & Anderson, 2013) also plays an important role in predicting degree of 
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impairment.  In the present study, it was hypothesized that higher cerebral tissue damage, as 
assessed by lesion volume and volume of the entire brain and thalamus, will contribute to worse 
performance on the Go/No-go task.  Results showed that lesion volume was not correlated with 
reaction time on the Go/No-go task. However, T2-weighted lesion volume and T1-weighted 
lesion volume both showed a negative association with accuracy (p = 0.08 and p = 0.098, 
respectively).  The observed weak relationship between lesion volume and reaction time is 
consistent with prior studies showing a weak relationship between lesion volume and cognitive 
dysfunction (Benedict et al., 2004; Till et al., 2011; Till et al., 2012). These findings suggest that 
lesion volume may not be sensitive enough to the subtle changes that occur in the brain that 
could be responsible for cognitive impairment (Rovaris et al., 1998, Rovaris et al, 2006). There 
are several reasons why the relationship between lesion volume and RT was not seen: First, the 
lesions may not exert strong influence on simple reaction time (for example, reaction time may 
be more dependent upon white matter integrity); Second, the “lesion volume” metric does not 
provide information regarding the spatial topography of the lesions (i.e. unclear whether the 
lesions consist of a number of small lesions throughout the brain or a large lesion) (Rovaris et al., 
1998; Rovaris et al, 2006). Third, the overall lesion volume was quite low in the current sample 
of patients relative to other samples of MS patients.  
In the current study, patients exhibited lower normalized brain volume compared to 
controls (p = 0.003), and lower thalamic volume compared to controls, with the difference 
approaching significance (p < 0.06). Brain volume represents the overall health of the brain. 
Patients with pediatric-onset MS exhibit reduced normalized brain volumes suggesting an overall 
failure of the brain to develop at a rate that is age appropriate (Kerbrat et al., 2012; Till et al., 
2011). Volume loss in the thalamus can occur before observable volume loss in the entire brain 
(Kerbrat et al., 2012; Mesaros et al., 2008). Measures detecting changes in individual subcortical 
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grey matter structures are more sensitive than measuring whole brain volume changes. The 
thalamus plays an important role in cognition as a result of its extensive circuitry connecting 
multiple brain regions that influence global cognitive functioning, attention, arousal, memory, 
mental processing speed, visuomotor integration, and expressive vocabulary (Blinkenberg et al., 
2000; Houtchens et al., 2007; Till et al., 2011; Van Der Werf et al., 2001). Our results are similar 
to Till et al., (2011) who found a significant difference in both normalized brain volume and 
thalamic volume between pediatric-onset patients with MS and healthy controls, with patients 
exhibiting lower thalamic and normalized brain volume.  
Objective 3.  To examine whether cognitively intact childhood-onset MS patients produce a 
less efficient pattern of cerebral activation compared with age-matched healthy controls  
 It was hypothesized that pediatric-onset MS patients would recruit supplementary 
cerebral areas, in addition to expected brain regions, when performing a simple Go/No-go task, 
compared to healthy controls. In the present study controls showed the expected pattern of 
activation whereas patients did not (Simmonds et al., 2008; Bonnet et al., 2010) however some 
differences did exist. Counter to our hypothesis, a more extensive pattern of brain activation was 
noted in controls as compared with the patient group in response to the No-go stimulus.  
Previous literature in healthy controls has identified the inferior occipital gyrus, fusiform 
gyrus/posterior cerebellum, pre-SMA and precuneus as regions that are activated during the 
response inhibition component of the simple Go/No-go task (Simmonds et al., 2008). In patients 
with MS, the cingulate gyrus, cerebellum, temporo-occipital region, temporal gyrus and medial 
frontal gyrus have been identified as regions involved in inhibitory control (Bonnet et al., 2010). 
When activation patterns were examined within groups, controls showed regions of 
activation that were similar to previous literature, but also recruited additional brain regions. 
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Amongst controls relative to patients, activations were more prominent in the occipital region 
(versus an absence of activation in this entire region in the patients), parietal lobe (including the 
precuneus and superior parietal lobe), frontal regions (superior frontal gyrus and the precentral 
gyrus/SMA), and posterior regions of the brain (including the cerebellum and 
brainstem/midbrain).Controls also showed activation patterns similar to those identified in 
previous literature for patients with MS (Bonnet et al., 2010), including the cingulate gyrus with 
bilateral activation, right cerebellum, right lateral occipital cortex, right temporal lobe and left 
temporal gyrus, and bilaterally in the medial frontal gyrus (see table 2). Unlike previous 
literature, controls showed activation bilaterally in the parietal lobe and left superior parietal 
lobe.  
When patients were examined as a group they showed activation in the right precuneus 
and left fusiform gyrus, as stated in literature on healthy controls (Simmonds et al., 2008) and 
additionally in the right superior and middle frontal gyri, right parietal lobe and left inferior and 
middle temporal gyri. Unlike previous literature on patients with MS (Bonnet et al., 2010), 
patients did not show activation in the right cingulate gyrus, right temporo-occipital lobe, right 
temporal gyrus or the medial frontal gyrus.  
When the two groups were compared, controls showed stronger activation in the right 
superior frontal gyrus, left superior parietal lobe, precuneus, right cerebellum, precentral gyrus 
(bilaterally), left parahippocampal gyrus, right lateral occipital cortex, and left brainstem.  
The simple Go/No-go task can be separated into two components: visual perception and 
response execution. These two components each have specific brain regions that are required to 
perform the task well. In terms of visual perception, the inferior occipital gyrus, temporal gyrus, 
and fusiform gyrus each play an important role in stimulus recognition. The occipital gyrus plays 
an important role in vision, particularly with respect to colour, and pattern, with an important 
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role in stimulus recognition (Barrett et al., 2001; Wang et al., 2013). In addition, the temporal 
gyrus is involved in higher order vision, such as visual control of actions with recognition and 
object identification occurring in the inferotemporal cortex and projecting to the posterior 
parietal region in order to mediate the required sensorimotor actions toward an object (Betts & 
Wilson, 2010; Goodale & Milner, 1992). The temporal and occipital gyri are interconnected, and 
communicate information to one another during stimuli recognition, particularly with whole face 
stimuli, but also with facial features and head outlines (Betts & Wilson, 2010).  The fusiform 
gyrus located in the temporal lobe is also a visual association area that is connected with the 
posterior parietal and prefrontal areas (Bullier, Schall, & Morel, 1996; Sporns, 2011). Activation 
in the fusiform gyrus is associated with correctly classifying a cue. Feedback from higher order 
regions is then used to recognize the cue, which in turn projects the information forward in order 
to inhibit the pre-potent response (Simmonds et al. 2008). In the present study, both groups 
showed activation in the fusiform/posterior cerebellum, temporal gyrus, with controls showing 
activation in the occipital gyrus and parietal lobe and prefrontal activation. 
 In terms of response execution, the cingulate gyrus, precuneus, pre-SMA, cerebellum and 
medial frontal gyrus all play an important role during the Go/No-go task. The posterior and 
anterior cingulate gyrus make up part of the attentional system and are thought to play roles both 
in attention and motivation (Rubia, Smith, Brammer, Toone, & Taylor, 2005). Specifically 
activity in the posterior cingulate gyrus is associated with unsuccessful inhibition whereas 
activity in the anterior cingulate gyrus is associated with successful inhibition. Previous literature 
on Attention Deficit Hyperactivity Disorder (ADHD) has pointed to the idea that reduced 
activation in the posterior cingulate reflects an inability to appropriately attend to stimuli after 
making errors (Rubia et al., 2005).  The role of the anterior cingulate cortex has also been 
implicated in reward processing, performance monitoring, execution of control, and action 
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selection (Shenhav, Botvinick, & Cohen, 2013). The anterior cingulate gyrus uses performance 
monitoring to decide the amount of control needed to execute an action (Shenhav et al., 2013). 
The precuneus is involved in movement initiation and control (Rocca et al., 2005), and, with its 
connections to the medial prefrontal cortex and inferior parietal cortex, plays a partnering role in 
order to promote efficient information flow and to enable higher intellectual performance 
(Sporns, 2011). In the present study, only controls showed activation in the cingulate gyri 
suggesting more attention spent on monitoring performance. Both controls and patients showed 
activation of the precuneus, parietal lobe, superior and middle frontal gyri, which all play a 
partnering role in enabling higher intellectual performance; however, only controls activated the 
entire frontal lobe and medial frontal gyri. Although behaviorally there was no significant 
difference in performance on the Go/No-go task, perhaps if the stimuli were more difficult to 
discern and a greater need for monitoring stimuli was required, the controls would perform better 
than patients given that these areas are already activated. 
 The pre-SMA is connected to prefrontal regions, the primary motor regions and the spinal 
cord (Picard & Strick, 2001). These connections suggest the pre-SMA plays a role in the ability 
to switch from the execution of a response (which is automatic) to the withholding of a response 
by listening to feedback from higher order areas like the prefrontal regions (Simmonds et al., 
2008). Frontal lobe lesion studies have documented an association between poor response 
inhibition and lesions in the superior medial frontal lobe, suggesting that the medial frontal lobe 
plays a role in not only inhibiting a response but also rapidly inhibiting that response (Floden & 
Stuss, 2006; Picton et al., 2006). The medial frontal gyrus is important in decision-making, as 
indicated by a study examining gambling behaviours in patients with bilateral lesions to the 
ventromedial prefrontal cortex (Bechara, Tranel, & Damasio, 2000). These patients had 
difficulty in decision-making throughout the task, and also demonstrated a lack of sensitivity to 
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consequences. In the present study, only controls activated the frontal lobes, superior, inferior, 
middle and medial frontal gyri, and precentral gyrus; the patients only showed activation in the 
right superior and middle frontal gyri. In Bonnet et al., (2010), better performance on the Go/No-
go by patients with MS was correlated with greater activation of the medial frontal gyrus. A 
difference between our patients and those in Bonnet et al. (2010) may be that their patients were 
diagnosed with MS in adulthood where their frontal lobes and connections were fully established 
whereas in our patient group the disease onset occurred prior to adulthood and thus the younger 
patients may be less able to recruit frontal regions because they were not developed normally.  
Moreover, in the comparison study, average disease duration was shorter than in the present 
study (1.4 ± 2.5 versus 5.07 ± 3.10 years), which may also contribute to differences in activation 
patterns between the studies.  
In the present study, only controls showed activation in the cerebellum and brainstem.  
The brainstem is important in many physiological functions (cardiac output, controlling blood 
pressure, respiration, sleep/wake cycle) thereby it is possible that the activation pattern observed 
in controls may have also resulted from physiological sources of noise (lying close to major 
arteries and CSF spaces) which may have generated time varying signals (Brooks, Faull, 
Pattinson, & Jenkinson, 2013), however this does not explain why we did not observe the same 
pattern in patients. Research has also pointed to the involvement of the brainstem when 
imagining a movement, such as when a person imagines performing a motor action (La Fourgere 
et al., 2010). This activation may have been observed in controls as they imagined their actions 
to the stimuli, which may have been part of their monitoring of their own actions. 
The cerebellum is important in motor preparation and response inhibition, with increased 
cerebellar activity associated with increased frontal lobe activity as task demands increase (Smith 
et al., 2009). The cerebellum also plays an important role in the execution of voluntary 
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movement, even when movement is inhibited (Mostofsky et al., 2003). An fMRI study 
examining motor control in patients with MS (Saini at al., 2004) found that patients displayed 
significant connectivity between the left premotor neocortex and the ipsilateral cerebellum. The 
authors suggested that these changes in functional connectivity in the patient group reflect 
adaptive changes in the brain following brain insult and serve the purpose of aiding the patient in 
his ability to sustain motor control (Saini at al., 2004).  
In recent years, the importance of the cerebellum has been highlighted in a variety of 
cognitive processes, including language, visual-spatial, executive control and working memory 
processes, but the precise role of the cerebellum in these cognitive processes still requires further 
investigation (Stoodley, 2012). The role of the cerebellum in motor tasks includes preparation 
and execution of movements (Cui et al., 2000) and previous literature in patients with MS has 
shown increased connectivity and bilateral cerebellar activity, consistent with adaptive changes 
to brain insult (Saini et al., 2004). However, other studies conducted in MS show decreased 
activation or connectivity of this brain structure, consistent with the current results showing a 
lack of activation in the cerebellum.  
Recent work has been examining the structure and function of the cerebellum in MS 
patients to understand its role better. In one study that used DTI to examine white matter 
integrity, adult MS patients who were cognitively impaired were shown to have reduced white 
matter integrity in cortical brain areas, thalamus, uncinate fasiculus, brainstem and cerebellum 
(Hulst et al., 2013).  Likewise, in patients with pediatric-onset MS, cognitive impairment was 
associated with gray matter and white matter atrophy in the posterior brain regions, suggesting a 
degeneration of axons passing through focal lesions and areas of demyelination (Rocca et al., 
2014).  The cerebellar cortex is affected early in MS which, in turn, may result in a failure of 
patients to recruit this structure, as suggested by findings in the present study (Calabrese et al., 
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2010). A decrease in performance between controls and patients may not have been seen as a 
result of the fact that the Go/No-go is a simple task of inhibition and patients are still capable of 
performing this task fairly well even without the support from the cerebellum. If the inhibitory-
response task became more complex it is possible that the lack of contribution from posterior 
brain regions, such as the cerebellum, would have had a notable functional impact on the 
patients’ performance.  
 Limitations. First, both patients and controls made very few errors due to the low 
cognitive demand of the simple Go/No-go task, with accuracy ranging from 92-100% in controls 
and 91-99% in patients.  It is possible that the green “go” stimulus and the red “no-go” stimulus 
are so familiar that recognition of these two stimuli has become part of an automatic response, 
requiring very little ‘executive control’ by the participants. Therefore, the results may have been 
limited by a ceiling effect.  As such, certain activation patterns may not have been observed in 
the current study since the task was not difficult for either group.  
Second, while the whole brain approach could potentially provide more information on 
many different areas involved in response inhibition, this approach also provides significant 
activation patterns that result from Type 1 error from the sheer number of comparisons made 
between voxels.  
Conclusion 
 In the present study, both patients and controls performed similarly on a simple Go/No-
go.  Lower accuracy on the Go/No-go task trended with younger age at disease onset and higher 
lesion volume, suggesting that patients with a young onset of disease and/or higher lesion burden 
are less proficient in terms of response inhibition. In the present study, controls showed greater 
activation than patients in the cerebellum, brainstem, lateral occipital cortex, parahippocampal 
76 
 
gyrus, precuneus, superior parietal lobe, precentral gyrus and superior frontal gyrus. These 
differences may have been observed as result of the diffuse damage to the posterior regions of 
the brain known to be affected in pediatric-onset MS patients. Despite these significant 
differences in activation patterns, patients were able to perform the GNG task as well as controls. 
The present results suggest that MS is impacting a widespread functional network, including 
both frontal and posterior brain regions that are involved in response inhibition. 
 Although a direct comparison between our fMRI results and structural results were not 
possible in the present study, future work should determine if the observed results are consistent 
with those of previous studies examining topographic changes in white and gray matter (Kerbrat 
et al., 2012; Mesaros et al., 2008). Future work should also examine how greater brain lesion 
volume correlates with activation in the frontal regions, which are known to play an important 
role in decision-making and response inhibition (Bonnet et al., 2010; Bechara et al., 2000). This 
will assist in providing insight into the disease progression hypothesis. Future studies can also 
examine functional reorganization and the influence of age at disease onset and degree of brain 
pathology by using a longitudinal design. 
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